Document:

<PAGE>

                                                                   Exhibit 10.40

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

                                                                       EXECUTION

                           SOFTWARE LICENSE AGREEMENT

     This Software License Agreement (this "Agreement"), dated as of January 10,
2003, is among LIFFE ADMINISTRATION AND MANAGEMENT, a company incorporated in
England and Wales ("LIFFE"), and BOARD OF TRADE OF THE CITY OF CHICAGO, INC., a
Delaware corporation (the "CBOT"). Capitalized terms used but not otherwise
defined herein shall have the meanings ascribed thereto in Section 1.

                                    RECITALS

     A. LIFFE has devised and developed an automated derivatives trading and
order matching system known as "LIFFE CONNECT(TM)" to facilitate the trading of
certain securities, futures, and options contracts.

     B. The CBOT wishes to obtain from LIFFE a license to use and/or access
certain components of the LIFFE CONNECT system, and certain other software as
LIFFE may develop or provide pursuant to any Development Services Agreement
and/or Managed Services Agreement that may be entered into by LIFFE and the
CBOT.

     C. LIFFE has agreed to license to the CBOT, subject to the terms and
conditions hereof, the right (a) to use and/or access certain components of the
LIFFE CONNECT system as well as any Upgrades as LIFFE may provide pursuant to
any Managed Services Agreement between LIFFE and the CBOT, and any software that
may be developed or provided by LIFFE pursuant to any Development Services
Agreement and/or Managed Services Agreement that may be entered into by LIFFE
and the CBOT; and (b) to sublicense the right to use and/or access the API
and/or other Interfaces to Members, Independent Software Vendors, Quote Vendors,
and other Persons wishing to participate in the CBOT Electronic Exchange.

     In consideration of the recitals and the mutual covenants and agreements
hereinafter set forth, the Parties hereto (each a "Party" and collectively the
"Parties") agree as follows:

                                    AGREEMENT

1.   Definitions

     In this Agreement, the following expressions shall mean, respectively:

     "AAA" shall have the meaning set forth in Section 19.3.

     "AAA Rules" shall have the meaning set forth in Section 19.3.

     "Affiliate" means any Person that, directly or indirectly, controls, is
     controlled by or is under common control with a specified Person.

     "Agreement" shall have the meaning set forth above.

     "Amendment No. 4" shall have the meaning set forth in Section 25.

     "API" means the LIFFE CONNECT application programming interface from a
     Trading Application to the Trading Host.

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

     "Arbitration Fees" shall have the meaning set forth in Section 19.3.7.

     "Auditor" shall have the meaning set forth in Section 3.2.2.2.

     "Bug Fixes" means any patch or other changes or modifications created for
     the primary purpose of remedying a defect in the Software.

     "Business Day" means any calendar day other than any Saturday, Sunday, U.S.
     bank holiday, and U.K. public or bank holiday.

     "CBOT Electronic Exchange" means the electronic facility for the trading of
     derivatives products listed from time to time by the CBOT in its capacity
     as a derivatives exchange.

     "CBOT Indemnitees" shall have the meaning set forth in Section 17.1.

     "CBOT Open Outcry Facility" means the open outcry facility for the trading
     of derivatives products listed from time to time by the CBOT in its
     capacity as a derivatives exchange.

     "CBOT's Premises" means those locations owned or controlled by the CBOT.

     "CBOT's Property" shall have the meaning set forth in Section 13.2.

     "CBOT Technology" means any software or equipment (other than Equipment) or
     other technology owned by the CBOT or licensed to the CBOT by a Person
     other than LIFFE.

     "CFTC" means the United States Commodity Futures Trading Commission.

     "Claim" shall have the meaning set forth in Section 17.1.

     "Confidential Information" shall have the meaning set forth in
     Section 14.1.

     "Contractor" shall have the meaning set forth in the Interface Sublicense
     Agreement.

     "Control" or "control" means the possession, direct or indirect, of fifty
     percent (50%) or more of the equity interests of another Person or the
     power otherwise to direct or cause the direction of the management and
     policies of such other Person, whether through ownership of voting
     securities, by contract or otherwise.

     "Delegate" means a Person who has leased a CBOT membership from a Member in
     accordance with CBOT rules and is thereby subject to the transaction fees
     applicable to Delegates with respect to the CBOT mini-Eurodollar futures
     contract.

     "Deposit Materials" shall have the meaning set forth in Section 7.1(a).

     "Development Services Agreement" means any agreement that may be entered
     into by LIFFE and the CBOT subsequent to the Effective Date, pursuant to
     which LIFFE agrees to develop software applications for the CBOT Electronic
     Exchange.

     "Development Services Deliverables" means any software and/or documentation
     provided to the CBOT by LIFFE pursuant to any Development Services
     Agreement, which software and/or

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       2

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

     documentation has been accepted by the CBOT pursuant to the terms of such
     Development Services Agreement.

     "Disputes" shall have the meaning set forth in Section 19.1.

     "Documentation" means, collectively, the operating manuals, user
     instructions, technical literature, and other documentation supplied by
     LIFFE to the CBOT for purposes of assisting the CBOT's use of and/or access
     to the Software, including such documentation set forth in Part 2 of
     Schedule A.

     "Effective Date" shall mean January 10, 2003.

     "Equipment" means the computer hardware including processors, memory,
     discs, screens, printers, routers, and hubs to be used with the Software.

     "Escrow Agreement" shall have the meaning set forth in Section 7.1.

     "eSpeed" means eSpeed, Inc., a corporation organized and existing under the
     laws of the State of Delaware, having a place of business at 299 Park
     Avenue, 29th Floor, New York, New York 10171-0002.

     "Euronext.liffe Exchanges" means the market administered by LIFFE and all
     other derivatives trading markets comprised in the Euronext N.V. Group of
     Companies as of the Effective Date.

     "Euronext N.V. Group of Companies" means, collectively, Euronext N.V., a
     company organized under the laws of the Netherlands, and all Affiliates of
     Euronext N.V.

     "Exclusivity Period" shall have the meaning set forth in Section 3.4.

     "Fees" shall have the meaning set forth in Section 9.1.

     "First Renewal Term" shall have the meaning set forth in Schedule I.

     "Force Majeure Event" means any cause beyond a Party's reasonable control,
     including, but not limited to, any flood, riot, fire, judicial or
     governmental action, and labor disputes.

     "Go-Live Date" means that date, agreed by the Parties, upon which the
     Software is made available for use in a real time live trading environment.

     "Holdings" shall have the meaning set forth in Section 25.

     "ICDR" shall have the meaning set forth in Section 19.3.

     "Independent Software Vendors" and "ISVs" mean those independent software
     providers who develop systems via which access to the Trading Host may be
     achieved.

     "Initial Term" shall have the meaning set forth in Section 10.1.

     "Interface Sublicense Agreement" shall have the meaning set forth in
     Section 5.1.

     "Interfaces" means, collectively, the API, the trade data interface, audit
     data interface, standing data interface and market data interface.

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       3

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

     "License" shall have the meaning set forth in Section 2.

     "License Fee" means the fee for the License, as specified in Schedule I.

     "Licensed Technology" means, collectively, (a) the object code versions of
     the Software and (b) the Documentation.

     "LIFFE CONNECT" means the electronic trading platform which is proprietary
     to LIFFE, as such trading platform may be modified from time to time.

     "LIFFE Indemnitees" shall have the meaning set forth in Section 17.2.

     "LIFFE Property" shall have the meaning set forth in Section 13.1.

     "Location" means those premises where the Software listed in Part 1 of
     Schedule A is to be installed, as specified in Schedule B.

     "Losses" shall have the meaning set forth in Section 17.1.

     "Malicious Code" means any computer virus, Trojan horse, worm, time bomb,
     or other similar code or hardware component designed to disrupt the
     operation of, permit unauthorized access to, erase, or modify the Licensed
     Technology or any operating system upon which the Licensed Technology is
     installed, excluding security keys or other disabling elements of any
     Software, which elements are designed to effect restrictions on the length
     of time during which any Software may be used or the number of persons who
     may use such Software.

     "Managed Services Agreement" means any agreement that may be entered into
     by LIFFE and the CBOT subsequent to the Effective Date, pursuant to which
     LIFFE agrees to provide the CBOT services relating to the operation and
     support of the CBOT Electronic Exchange.

     "Market Data" means any representation that conveys, either directly or
     indirectly, information and data pertaining to futures and/or options
     traded on the CBOT including, but not limited to, market prices of such
     futures or options, opening and closing price ranges, high-low prices,
     settlement prices, estimated and actual contract volume, information
     regarding market activity including exchange for physical transactions,
     best bid, best offer, the size of the best bid or best offer or a discrete
     number of best bids and best offers then pending on the CBOT Electronic
     Exchange along with the corresponding size of each bid and offer.

     "Media" means the media on which the Software and the Documentation are
     recorded or printed as provided by LIFFE to the CBOT.

     "Member" means any Person authorized by the CBOT to trade on the CBOT
     Electronic Exchange.

     "Non-Restricted Documentation" means all Documentation other than
     Restricted Documentation, including the Documentation identified in Part
     2(a) of Schedule A.

     "[**]" shall have the meaning set forth in Section 3.2.2.2.

     [**] shall have the meaning set forth in section 3.3.1.

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       4

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

     "Out of Pocket Expenses" shall have the meaning set forth in Section 9.1.

     "Party" and "Parties" shall have the meanings set forth above.

     "Person" means an individual or a partnership, corporation, limited
     liability company, trust, joint venture, joint stock company, association,
     unincorporated organization, government agency or political subdivision
     thereof, or other entity.

     "Products Outside CBOT Field of Use" [**]

     "Products Within CBOT Exclusive Field of Use" [**]

     "Products Within CBOT Non-Exclusive Field of Use" [**]

     "Quote Vendors" and "QVs" mean those vendors who receive and disseminate,
     or wish to receive and disseminate, Market Data.

     "Registration Statement" shall have the meaning set forth in Section 25.

     "Relationship Manager" means that individual responsible on behalf of LIFFE
     or the CBOT, as applicable, for the day to day management of the
     relationship between LIFFE and the CBOT.

     "Release Period" shall have the meaning set forth in Section 7.1(d).

     "Renewal Term" shall have the meaning set forth in Section 10.2.

     "Restricted Documentation" means Documentation that is designated by LIFFE
     as "LIFFE Restricted" or otherwise specified by LIFFE to be restricted,
     including the Documentation set forth in Part 2(b) of Schedule A.
     Notwithstanding the foregoing, all documentation provided by LIFFE to the
     CBOT prior to the Effective Date which is labeled "LIFFE Confidential" is
     Restricted Documentation for purposes of this Agreement unless LIFFE, upon
     the CBOT's inquiry, notifies the CBOT in writing that specific
     Documentation is not "Restricted Documentation."

     "SEC" shall have the meaning set forth in Section 25.

     "Second Renewal Term" shall have the meaning set forth in Schedule I.

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                        5

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

     "Software" means, collectively, those software applications specified in
     Part 1 to Schedule A, any Development Services Deliverables, and any
     improvements, enhancements, additions, and modifications to or of the
     foregoing as LIFFE may provide to the CBOT pursuant to the terms of any
     Managed Services Agreement.

     "Sublicensee" means any Member, ISV, QV or other Person to which the CBOT
     wishes to sublicense a portion of the Licensed Technology.

     "Taxes" shall have the meaning set forth in Section 9.2.

     "Termination Notice Period" shall have the meaning set forth in Section
     11.2.1.

     "Third Party Materials" means any equipment, hardware, software, and/or
     other products obtained from any third party.

     "Trading Application" means any front-end trading application or other
     software which interfaces with, and has been conformed with, the API.

     "Trading Host" means the LIFFE CONNECT matching engine as may be developed
     for the CBOT pursuant to the Development Services Agreement and used on
     such Equipment as LIFFE may specify from time to time.

     "TRS Technology" means that post-trade matching and clearing technology
     used, as of the Effective Date, by LIFFE and the International Petroleum
     Exchange, specifically, [**]

     "Upgrades" means, collectively, improvements, enhancements, additions and
     modifications to and of the Licensed Technology or any portion thereof
     which LIFFE specifies for use and/or access as Licensed Technology.

     "U.S." means the United States of America.

     "Wagner/eSpeed Patent" means U.S. Letter Patent No. 4,903,201 (the '201
     patent).

     "Wagner License" shall have the meaning set forth in Section 16.2.

2.   License

     2.1 Grant of License. Subject to the terms and conditions hereof, LIFFE
hereby grants to the CBOT a non-transferable right and license (the "License"):

     (a)  from the Effective Date to the Go-Live Date, to use and/or access the
          Licensed Technology as necessary for purposes of carrying out any
          rights or obligations of the CBOT pursuant to any Development Services
          Agreement; and

     (b)  from the Go-Live Date to the effective date of termination of this
          Agreement, (i) to use and/or access the TRS Technology for purposes of
          operating the CBOT Electronic Exchange and the CBOT Open Outcry
          Facility; (ii) to use and/or access the Licensed Technology (excluding
          the TRS Technology) solely for purposes of operating the CBOT
          Electronic Exchange; and (iii) to sublicense the right to use and/or
          access the Interfaces and Documentation relating thereto to facilitate
          the participation in the CBOT Electronic Exchange of Sublicensees.

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       6

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

     2.2 Hosting. The CBOT shall not use the Licensed Technology, or any
component thereof, to facilitate the trading of any derivative product, physical
commodity or financial instrument listed by (a) any U.S. domiciled "organized
exchange," "board of trade" or "trading facility" (as each such term is defined
in the Commodity Futures Modernization Act of 2000) under the jurisdiction of
the CFTC, other than the CBOT, or (b) any other third party exchange, board of
trade, association, communication network, alternative trading system, trading
facility or trading platform. For the avoidance of doubt, the foregoing
limitation of the scope of the License shall not apply to Trading Applications.

3.   Scope of License

     The Parties acknowledge that (a) they will be making a significant
investment in the customization and implementation of the Licensed Technology to
trade products listed by the CBOT and the Euronext.liffe Exchanges,
respectively, and (b) carrying out their obligations under this Agreement and
any Development Services Agreement and/or Managed Services Agreement will
necessitate access to the Confidential Information of the other Party relating
to such other Party's respective products, technologies, and business
methodologies. Therefore, in accordance with and subject to Sections 3.1 - 3.6
below, the License is:

          (i)  during the Exclusivity Period, (x) exclusive, to the extent set
               forth in Section 3.1, with respect to use of the Licensed
               Technology in connection with Products Within CBOT Exclusive
               Field of Use; and (y) non-exclusive with respect to use of the
               Licensed Technology in connection with Products Within CBOT
               Non-Exclusive Field of Use; and

          (ii) after the Exclusivity Period, non-exclusive with respect to use
               of the Licensed Technology in connection with any futures or
               options products.

     3.1 Exclusive License Granted to CBOT. In order to preclude free riding on
the significant investment by the CBOT in the customization of LIFFE CONNECT
pursuant to any Development Services Agreement, and to protect the Confidential
Information of the CBOT and other intellectual property concerning the CBOT's
products, technologies, and business methodologies, LIFFE agrees that, subject
to Sections 3.3.1 and 4, Products Within CBOT Exclusive Field of Use will not be
made available for trading on LIFFE CONNECT:

          (a)  by (i) the Euronext.liffe Exchanges and (ii) any derivatives
               trading market which becomes comprised in the Euronext N.V. Group
               of Companies after the Effective Date, to the extent that such
               derivatives trading market is not already trading Products Within
               CBOT Exclusive Field of Use at the time that it becomes comprised
               in the Euronext N.V. Group of Companies (but, for the avoidance
               of doubt, no clearing, settlement, or custody-related activities
               of the Euronext N.V. Group of Companies shall be deemed to
               violate the foregoing limitations); or

          (b)  as a consequence of the licensing of LIFFE CONNECT by LIFFE to a
               U.S. domiciled "organized exchange," "board of trade" or "trading
               facility" (as such terms are defined in the Commodity Futures
               Modernization Act of 2000) under the jurisdiction of the CFTC, as
               such CFTC jurisdiction is established as of the Effective Date,
               whether or not such exchange, board of trade or trading facility
               is a member of or becomes comprised in the Euronext N.V. Group of
               Companies (but, for the avoidance of doubt, such limitations
               shall not apply in respect of any other exchange, board of trade,
               association, communication network, alternative

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       7

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

                trading system, trading facility or trading platform, whether or
                not its products are made available for trading in the U.S.
                and/or to U.S. investors).

     3.2 Scope of CBOT License.

          3.2.1 General Restrictions. In recognition of the significant
                investment that LIFFE has made in the customization and
                implementation of the Licensed Technology to trade products
                listed by the Euronext.liffe Exchanges, and to protect the
                Confidential Information of LIFFE, and subject to Sections 3.2.2
                and 3.4, the CBOT agrees that the license granted hereunder does
                not include the right to use the Licensed Technology in
                connection with Products Outside CBOT Field of Use.

          3.2.2 Eurodollars.

                    (i)  3.2.2.1 Payment. The CBOT may make available for
                         trading on the Licensed Technology the CBOT's existing
                         U.S. $500,000 notional value Eurodollar futures
                         contracts provided that if, during any calendar
                         quarter, the [**] in such CBOT Eurodollar futures
                         contracts on the Licensed Technology exceeds [**] then
                         the CBOT shall pay to LIFFE an amount equal to [**]

               The CBOT shall make any such payment by the end of the month
               immediately following the end of the relevant calendar quarter.
               The CBOT's obligations under this Section 3.2.2.1 shall apply in
               respect of CBOT Eurodollar futures contracts traded on the
               Licensed Technology up to and including [**]

               3.2.2.2. Audit. LIFFE shall have the right, at its own expense,
                        to commission an independent third party professional
                        organization (the "Auditor") to audit the CBOT's
                        performance of its obligations under Section 3.2.2.1
                        and to provide the results of such audit to [**]. The
                        CBOT shall cooperate fully with any such audit and shall
                        provide the Auditor access to all relevant books and
                        records, during normal business hours or as otherwise
                        agreed by the Parties. Notwithstanding the foregoing,
                        the information that may be disclosed by the Auditor to
                        LIFFE and [**] shall be subject to Section 14 and will
                        be limited to (a) the amount that was paid to LIFFE by
                        the CBOT in respect of each calendar quarter forming the
                        subject of the audit and (b) the amount that should
                        properly have been paid to LIFFE by the CBOT during each
                        such calendar quarter.

     3.3  Third Party Licensees.

          3.3.1 [**]

          3.3.2 Other Licensees. LIFFE will take all commercially reasonable
                steps (including pursuing court proceedings) to ensure that
                neither any licensee of LIFFE CONNECT other than the CBOT, nor
                any other Person, contravenes the exclusivity limitations set
                forth in Section 3.1. For the avoidance of doubt, preparatory
                work up to the date on which products are made available for
                trading

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       8

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

               in the live market may be undertaken within the Exclusivity
               Period by any licensee of LIFFE CONNECT or any other Person
               without triggering LIFFE's obligations under the preceding
               sentence.

     3.4 Exclusivity Period. Subject to Section 3.5, the field of use and
exclusivity limitations set forth in Sections 3.1 and 3.2.1 shall take effect
upon the Effective Date and will remain in force until [**] (the "Exclusivity
Period"). Thereafter, subject to Section 2.2, the CBOT shall be permitted to
make any futures and options products available for trading via the Licensed
Technology on a non-exclusive basis. For the avoidance of doubt, preparatory
work up to the date on which products are made available for trading in the live
market undertaken within the Exclusivity Period will not constitute a breach of
the field of use or exclusivity limitations of Sections 3.1, 3.2 or 3.3.

     3.5 [**] In the event that LIFFE terminates this Agreement in accordance
with Section 11.2, then the CBOT shall not, during the Termination Notice
Period, make available for trading on the Licensed Technology (a) any product
that is listed by one or more of the Euronext.liffe Exchanges, as of the date
upon which notice of termination is given by LIFFE, or (b) any product that (i)
one or more of the Euronext.liffe Exchanges has publicly announced, prior to the
date notice of termination is given by LIFFE, it intends to launch and (ii) is
not traded by the CBOT on the Licensed Technology as of the date of any such
notice of termination is given by LIFFE.

     3.6 Acknowledgement. As of the Effective Date, (a) LIFFE is not subject to
any agreements which would materially affect its ability to grant the License,
and (b) the CBOT is not subject to any agreements which would materially affect
its ability to comply with the License.

     3.7 [**] The license granted hereunder includes the right to use the
Licensed Technology in connection with futures and options on the [**] only
pursuant to a joint listing arrangement mutually agreed upon by the Parties.

4.   Restrictions on Use

     4.1  Software.

          4.1.1 General Restrictions. The CBOT may (a) use and/or access the
                Software on the Equipment, only at the Locations set forth in
                Schedule B, and (b) have and make available for use only four
                (4) run-time copies of the Trading Host. With respect to all
                Software installed or otherwise located at or accessible from
                the CBOT's Premises and any other Software to which the CBOT is
                provided access, the CBOT agrees:

                (a) not to, and not to permit any other Person to, copy, modify,
                    decompile, reverse engineer, disassemble or otherwise reduce
                    to a humanly perceivable form, combine with any other works,
                    including any hardware or software facilitating the voice
                    activation of any component of the Licensed Technology, make
                    any attempt to discover the source code of, create
                    derivative works based on, translate, market, sell, or
                    distribute the Software or otherwise make the Software
                    available to any third party, without the prior written
                    consent of LIFFE, except as provided in Sections 2 and 4.1;

                (b) not to, and not to permit any other Person to, remove or
                    alter in any manner any trademarks, trade names, copyright
                    notices or other

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                        9

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

                    proprietary or confidentiality notices or designations, of
                    LIFFE or any other Person, contained or displayed in or on
                    the Software; or

               (c)  to ensure that neither the CBOT nor any other Person
                    (excluding LIFFE) introduces any Malicious Code into the
                    Software or otherwise uses the Software to further any
                    illegal purpose.

     For the avoidance of doubt, with respect to any Software to which the CBOT
     has access, the CBOT shall neither provide or allow [**] access, nor permit
     any other Person to provide or allow [**] access, to such Software or any
     portion thereof.

          4.1.2 Copies. Subject to Section 4.1, the CBOT may not copy the
                Software except that the CBOT may, for archival or backup
                purposes, make a reasonable number of copies of Software
                installed or otherwise located at the CBOT's Premises. All
                copies of the Software are subject to the terms and conditions
                of this Agreement. The CBOT shall (i) ensure that all
                trademarks, trade names, copyright notices and other proprietary
                and confidentiality notices or designations, of LIFFE or any
                other Person, contained or displayed in or on the Software are
                reproduced on all Software copies created by the CBOT; (ii)
                maintain a current and accurate record of the number of copies
                made and of the specific location of each such copy; and (iii)
                ensure that all backup copies are marked as such and are not
                used for any purpose other than as backup in the event of damage
                or destruction of other copies.

     4.2  Documentation.

          4.2.1 Non-Restricted. The CBOT may (a) distribute Non-Restricted
                Documentation to actual and prospective Sublicensees and to
                other Persons for purposes related to the operation of the
                CBOT Electronic Exchange by or on behalf of the CBOT; (b)
                create as many copies of the Non-Restricted Documentation as
                reasonably necessary for the purposes set forth in Section
                4.2.1(a); (c) permit Sublicensees to copy such Non-Restricted
                Documentation to the extent allowed by the Interface Sublicense
                Agreements; and (d) permit prospective Sublicensees to copy any
                Non-Restricted Documentation which is designed primarily for the
                purpose of marketing the CBOT Electronic Exchange.

          4.2.2 Restricted. The CBOT (a) may create only the number of copies of
                the Restricted Documentation specified in Part 2(b) of Schedule
                A; and (b) shall maintain a current record of (x) the number of
                copies of such Restricted Documentation made by the CBOT, (y)
                the Persons given access to each item of Restricted
                Documentation, and (z) the current location of each item of
                Restricted Documentation.

          4.2.3 General Limitations. All copies of the Documentation are subject
                to the terms and conditions of this Agreement. The CBOT shall
                ensure that all trademarks, trade names, copyright notices and
                other proprietary and confidentiality notices or designations,
                of LIFFE or any other Person, are reproduced on all copies of
                the Documentation (both Restricted and Non-Restricted). The CBOT
                agrees not to, and not to authorize any other Person to: (a)
                except as permitted in Sections 4.2.1, 4.2.2 and/or 14, as
                applicable, copy, modify, create derivative works based on,
                translate, market, sell, or distribute the Documentation, or
                otherwise make the

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       10

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

                Documentation available to any third party, without the prior
                written consent of LIFFE; or (b) remove or alter in any manner
                any trademarks, trade names, copyright notices or other
                proprietary or confidentiality notices or designations contained
                or displayed in the Documentation.

5.   Interface Sublicense Agreements

     5.1 Interface Sublicense Agreements. Each Member, ISV, QV, or any
additional Person wishing to interface with the API and/or another Interface and
to participate in the CBOT Electronic Exchange shall be required by the CBOT to
enter into, and provide to the CBOT an executed copy of, the "Interface
Sublicense Agreement," in the form attached hereto as Schedule E (each, as
executed by the CBOT and a Sublicensee, an "Interface Sublicense Agreement").
Amendments to any Interface Sublicense Agreement may be made only upon LIFFE's
prior written consent. Upon the written request of LIFFE, the CBOT shall
promptly provide to LIFFE copies of a current, fully executed Interface
Sublicense Agreement for each Sublicensee authorized to gain access to one or
more of the Interfaces.

     5.2  Enforcement. The CBOT:

          (a)  shall enforce each Sublicensee's compliance with the terms of the
               Interface Sublicense Agreement;

          (b)  shall provide LIFFE written notice of any violation by a
               Sublicensee or any other Person of any Interface Sublicense
               Agreement, immediately upon becoming aware of any such violation;

          (c)  shall provide LIFFE written notice of the termination (specifying
               the effective date of termination) of any Interface Sublicense
               Agreement, immediately upon the CBOT receiving or giving notice
               of such termination;

          (d)  shall upon the termination of any Interface Sublicense Agreement,
               provide LIFFE any reasonable assistance as LIFFE may request in
               facilitating either the return to LIFFE of, or the destruction of
               and certification of the destruction of, all Licensed Technology
               in the possession of the relevant Sublicensee, at the CBOT's
               expense;

          (e)  shall provide LIFFE written notice promptly upon becoming aware
               of any acts or omissions of any Person, in addition to those
               required to be reported pursuant to Section 5.2(b), which the
               CBOT believes, in its reasonable judgment, (i) might jeopardize
               or prejudice the rights of LIFFE or its suppliers in the Licensed
               Technology; (ii) would result in the Licensed Technology being
               confiscated, seized, requisitioned, taken in execution, impounded
               or otherwise taken from any location; or (iii) threaten the
               security or operations of the Licensed Technology.

          (f)  shall provide LIFFE written notice promptly upon becoming aware
               of any claim, demand, or cause of action brought against the CBOT
               by a Sublicensee or any other Person, or any subpoena served upon
               the CBOT or any employee, officer or director thereof, which
               relates to (i) any Interface Sublicense Agreement, or (ii) the
               Licensed Technology or any component thereof; and

          (g)  shall not repossess or disable any Software located at any
               premises owned or controlled by any Sublicensee, and shall
               enforce its rights under the Interface

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       11

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

                Sublicense Agreements so as not to permit any Person (other than
                LIFFE or LIFFE's designee) to repossess or disable any Software
                located at any premises owned or controlled by any Sublicensee,
                notwithstanding Section 5.2(a).

6.   Obligations of the CBOT and LIFFE

     6.1 Security. In addition to all other duties of the CBOT specified
hereunder in respect of Licensed Technology and the use or access thereof by the
CBOT, the CBOT shall use reasonable efforts to (a) comply with LIFFE's security
policy, a copy of which is attached as Schedule F hereto, and (b) establish and
maintain supervisory and security procedures satisfactory to LIFFE for the
purpose of protecting all Licensed Technology and LIFFE's rights, title and
interest in and to the Licensed Technology.

     6.2 Third Party Licenses. The CBOT shall enter into and comply with the
terms and conditions of those third party license agreements set forth in
Schedule G. The CBOT acknowledges and agrees that any rights or remedies to be
pursued by the CBOT in respect of any third party software shall be pursued
against the third party licensor (and not LIFFE).

     6.3 Upgrades. Subject to any applicable obligations of LIFFE pursuant to
any Managed Services Agreement entered into by the Parties, nothing herein shall
require LIFFE to (a) create any Upgrades or (b) license to the CBOT for use
and/or access as "Licensed Technology" hereunder any modifications,
enhancements, improvements or additions to the Licensed Technology as LIFFE may
choose to create. Notwithstanding the foregoing, in the event LIFFE delivers to
the CBOT any Upgrades pursuant to any Managed Services Agreement, the CBOT shall
install such Upgrades in accordance with the terms of such Managed Services
Agreement.

     6.4 Materials and Assistance. In order to facilitate the Parties'
performance of their obligations hereunder, the CBOT shall promptly provide to
LIFFE such information and documentation as LIFFE may reasonably request.

     6.5 Export Compliance. The CBOT and LIFFE each shall comply with all
applicable export laws and regulations of the United States and foreign
authorities, including regulatory authorities. For purposes of this obligation,
export laws and regulations include, but are not limited to, all applicable end
use controls and all applicable restrictions on the export, reexport and
transfer of encryption items.

7.   Escrow Agreement

     7.1 Terms. The Parties shall enter into a separate agreement with an escrow
agent specified by LIFFE, which agreement shall be substantially in the form of
the agreement attached as Schedule H (the "Escrow Agreement"). In addition to
any other terms upon which the Parties may agree, the Escrow Agreement will
provide:

          (a)  within six (6) months of the execution of the Escrow Agreement,
               but in no event earlier than the conclusion of the sixth month
               following the Go-Live Date, LIFFE shall deposit with the escrow
               agent that source code to the then current versions of the
               Software which has been developed by LIFFE or is available to
               LIFFE, all other software and documentation (including libraries,
               make files, and object code) necessary to build the Software, and
               Documentation relating thereto (collectively, the "Deposit
               Materials");

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       12

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

          (b)  the Deposit Materials will be updated quarterly;

          (c)  the Deposit Materials may be released only in accordance with the
               procedures set forth in the Escrow Agreement and upon the
               occurrence of one or more of the following release conditions:
               LIFFE (i) becomes insolvent, (ii) files for voluntary protection
               under the bankruptcy laws of the United States or England and
               Wales, or (iii) becomes subject to any involuntary bankruptcy or
               insolvency proceeding under laws of the United States or England
               and Wales (which proceeding is not dismissed by a court of
               competent jurisdiction within sixty (60) Business Days);

          (d)  upon release, the CBOT will be entitled to use such Deposit
               Materials for (i) a period not to exceed [**] months following
               the date of release of the Deposit Materials (the "Release
               Period"), and (ii) the sole purpose of continuing the CBOT's use
               of the Licensed Technology as permitted by this Agreement,
               provided that (x) the CBOT shall have the right to modify the
               source code of Deposit Materials comprising software only to the
               extent necessary to create Bug Fixes and (y) the CBOT shall be
               obligated to maintain the confidentiality of the released Deposit
               Materials; and

          (e)  the CBOT shall be responsible for payment of all fees and
               expenses owed to the escrow agent pursuant to the Escrow
               Agreement.

     7.2 Return of Deposit Materials. In the event the Deposit Materials are
released and, prior to any effective date of termination of the Release Period,
any involuntary bankruptcy or insolvency proceeding referenced in Section
7.1(c)(iii) is dismissed, then the CBOT shall (a) return to LIFFE all Deposit
Materials and any Bug Fixes created by or on behalf of the CBOT; (b) provide
LIFFE with any modified source code (including source code pertaining to any Bug
Fixes created by or on behalf of the CBOT); or (c) destroy any and all copies of
the Deposit Materials in the CBOT's possession and/or control, via a method that
renders all such copies permanently unrecoverable, and certify any such copies
as destroyed via such a method.

8.   Inspection, Removal, or Disablement of the Licensed Technology

     In the event that any Licensed Technology is located at the CBOT's
Premises, LIFFE shall be entitled to have reasonable access to the CBOT's
Premises and such Licensed Technology, and:

     (a)  to inspect such Licensed Technology or any portion thereof: (i) to
          determine whether the CBOT is complying or has complied with its
          obligations under this Agreement; and/or (ii) to facilitate LIFFE's
          efforts to remedy any defect or error in the Licensed Technology or
          any portion thereof; and

     (b)  to disable and/or to remove such Licensed Technology or any part or
          parts thereof (i) if the CBOT has failed or is failing to comply with
          its obligations under this Agreement; or (ii) to facilitate LIFFE's
          efforts to remedy any defect or error in the Licensed Technology or
          any portion thereof.

9.   Fees

     9.1 Payment. In consideration for the rights and licenses granted
hereunder, the CBOT shall, via wire transfer of immediately available funds to
such bank account as LIFFE may specify, (a) pay to LIFFE the License Fee in
accordance with Schedule I, and (b) reimburse LIFFE for any out of pocket

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       13

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

expenses incurred by LIFFE hereunder (collectively, "Out of Pocket Expenses")
(the License Fee and Out of Pocket Expenses, collectively, the "Fees"). All
payments hereunder shall be made in pounds sterling.

     9.2 Taxes. The Fees are exclusive of all international, national or state
taxes (including withholding taxes), levies, duties, or similar charges, however
designated, that may be assessed by any jurisdiction under current law or as a
result of any change in the law following the date thereof (collectively,
"Taxes"), and the CBOT shall pay or reimburse LIFFE for all such Taxes that may
be levied or imposed in relation to this Agreement or any of the rights and
licenses granted hereunder, excluding taxes based on the net income of LIFFE.
Prior to receiving from the CBOT any payment which may be subject to United
States withholding taxes, LIFFE shall deliver to the CBOT two original copies of
Internal Revenue Service Form "W-8BEN" (or any successor forms), accurately
completed and duly executed by LIFFE certifying, in Line 9a thereof (or the
corresponding line of any successor forms), that the applicable treaty is the
United States-United Kingdom Income Tax Convention, and further certifying the
matters set forth in Line 9b and 9c of Form "W-8BEN" (or the corresponding lines
of any successor forms). LIFFE hereby agrees, from time to time after the
initial delivery by LIFFE of such forms whenever a lapse in time or change of
circumstances renders such forms obsolete or inaccurate in any material respect,
to deliver to the CBOT two new original copies of Internal Revenue Service Form
"W-8BEN" (or any successor forms), accurately completed and duly executed by
LIFFE. Notwithstanding this Section 9.2, the relevant Fees shall be paid net of
any U.S. federal income withholding tax caused by the failure of LIFFE to
provide the CBOT with such forms, unless a change in applicable law of the
United States, enacted or promulgated after the date hereof, makes it impossible
for LIFFE to continue to make the certifications described above.

     9.3 Invoices. LIFFE shall invoice the CBOT for the License Fee in
accordance with Schedule I, in pounds sterling. LIFFE shall invoice the CBOT
monthly in arrears for the Out of Pocket Expenses and any additional amounts due
hereunder (excluding the License Fee), in pounds sterling. Payment of each
invoice shall be made by the CBOT within fourteen (14) days of the date of
receipt of such invoice by the CBOT, unless the CBOT makes a good faith
objection to the terms of the invoice, in which case (a) the CBOT shall pay the
undisputed amount of the invoice, and (b) the Parties shall promptly undertake
to resolve the disputed portion of the invoice.

     9.4 Suspension. If the CBOT fails to pay any undisputed sum due under this
Agreement, then, without prejudice to any other remedy available to LIFFE, LIFFE
may, upon fourteen (14) days prior written notice to the CBOT, suspend the
CBOT's License, provided that the CBOT has not made payment within such period
of time. In the event of reinstatement of the License, the CBOT will (i) pay
LIFFE for all work undertaken by LIFFE in connection with such reinstatement on
a time and materials basis in accordance with LIFFE's then current hourly rates
for comparable services, and (ii) the CBOT shall be required to install any such
Upgrades to the version(s) of the Licensed Technology last utilized by the CBOT,
as LIFFE may specify.

     9.5 Late Payment. If the CBOT fails to pay any undisputed Fees due under
this Agreement, then interest shall be charged thereon from the date of issuance
of the applicable invoice until the date payment is made, at the rate of the
lesser of one and one half percent (1.5%) per month, or the maximum amount
allowed under applicable law.

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       14

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

10.  Term

     10.1 Initial Term. The initial term of this Agreement shall commence on the
Effective Date and shall continue for a period of [**] years from the Go-Live
Date ("Initial Term"), unless terminated earlier in accordance with Section 11.

     10.2 Renewal. Unless terminated earlier in accordance with Section 11, THIS
AGREEMENT WILL AUTOMATICALLY RENEW FOR NO MORE THAN [**] SUCCESSIVE PERIODS OF
[**] YEARS (each, a "Renewal Term").

11.  Termination

     11.1 By the CBOT.

          11.1.1 Non-Renewal. The CBOT may terminate this Agreement, for any
                 reason, upon written notice to LIFFE provided at least [**]
                 months prior to the end of the Initial Term or the First
                 Renewal Term (if any).

          11.1.2 Development Services Agreement and Managed Services Agreement.
                 The CBOT may terminate this Agreement immediately upon notice
                 to LIFFE in the event that the Parties have not entered into
                 (a) a Development Services Agreement by [**] or (b) a Managed
                 Services Agreement by [**]

     11.2 By LIFFE.

          11.2.1 [**] LIFFE may terminate this Agreement, upon twelve (12)
                 months prior written notice to the CBOT ("Termination Notice
                 Period"), if [**] or any Affiliate of [**] directly or
                 indirectly acquires control of the CBOT.

          11.2.2 Development Services Agreement and Managed Services
                 Agreement. LIFFE may terminate this Agreement immediately
                 upon notice to the CBOT in the event that the Parties have not
                 entered into a Development Services Agreement and a Managed
                 Services Agreement by [**]

     11.3 By Either Party.

          11.3.1 Material Breach. Subject to Section 12.3, at any time during
                 the term of this Agreement, either Party may terminate this
                 Agreement immediately upon written notice to the other Party if
                 the other Party commits a breach of any of its material
                 obligations under this Agreement and fails to remedy such
                 material breach within thirty (30) days of receipt of written
                 notice thereof.

          11.3.2 Insolvency. At any time during the term of this Agreement,
                 either Party may terminate this Agreement upon thirty (30) days
                 prior written notice if: (a) the other Party (i) becomes
                 insolvent, (ii) voluntarily commences any proceeding or files
                 any petition under the bankruptcy laws of the United States or
                 England and Wales, (iii) becomes subject to any involuntary
                 bankruptcy or insolvency proceedings under the laws of the
                 United States or England and Wales, which proceedings are not
                 dismissed within thirty (30) days, (iv) makes an assignment for
                 the benefit of its creditors, or (v) appoints a receiver,
                 trustee, custodian or

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       15

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

                 liquidator for a substantial portion of, its property, assets
                 or business; or (b) the other Party passes a resolution for its
                 winding up or dissolution, or a court of competent jurisdiction
                 makes an order for such other Party's winding up or
                 dissolution.

     11.4 Automatic Termination. As maintenance services relating to the
Licensed Technology will be required (at a minimum), this Agreement will
terminate automatically upon termination of the Managed Services Agreement.

12.  Consequences of Termination

     12.1 Licensed Technology.

          12.1.1 In CBOT's Possession. Following termination of this Agreement,
                 the CBOT shall (a) immediately cease use of the Licensed
                 Technology; (b) at LIFFE's request and at the CBOT's expense,
                 (i) immediately return to LIFFE, or destroy and certify as
                 destroyed, any Licensed Technology in the CBOT's possession
                 and/or control (including all Documentation), and (ii) return
                 to LIFFE any and all other LIFFE Property in the CBOT's
                 possession and/or control; and (c) within fourteen (14) days of
                 the effective date of termination of this Agreement,
                 permanently erase and certify the erasure of the Software (and
                 all copies thereof) from the Equipment and all backup Media.

          12.1.2 In Sublicensees' Possession. Upon or prior to the effective
                 date of termination of this Agreement, the CBOT shall (a)
                 terminate all Interface Sublicense Agreements; (b) require each
                 Sublicensee, to which the CBOT has sublicensed the right to use
                 and/or access certain components of the Licensed Technology, to
                 (i) cease use of such Licensed Technology and (ii) promptly
                 return to LIFFE, or destroy and certify as destroyed, each item
                 of Licensed Technology in such Sublicensee's possession and/or
                 control (including all Documentation), and (iii) promptly
                 return to LIFFE any other LIFFE Property within such
                 Sublicensee's possession and/or control; and
                 (c) notwithstanding Section 12.1.2(b), return to LIFFE any
                 LIFFE Property that has been provided to the CBOT by any
                 Sublicensee, promptly upon the CBOT's receipt thereof.

     12.2 Third Party Obligations. In the event of termination of this
Agreement, LIFFE will use commercially reasonable efforts to terminate any
contracts with third parties relating to LIFFE's provision of the Licensed
Technology or other obligations hereunder (or relevant portions thereof).
Notwithstanding the foregoing, the CBOT shall be obligated to reimburse LIFFE
for any and all costs and expenses relevant to this Agreement for which LIFFE is
contractually obligated as of the termination hereof.

     12.3 Transition. In the event of LIFFE's notice of termination to the CBOT
pursuant to Section 11.3.1 for a material breach that is incapable of remedy,
the License provided hereunder shall continue for a period of up to [**] months
from the date upon which notice of termination is given (the "Transition
Period"); provided that, within thirty (30) days following notice of
termination, (a) the CBOT has accepted full liability for such material breach
via written notice to LIFFE in a form acceptable to LIFFE, in LIFFE's sole
discretion; and (b) the CBOT has submitted to LIFFE reasonable assurances that
it has employed measures sufficient to prohibit repetition of such material
breach. Notwithstanding the foregoing, (i) during any Transition Period, LIFFE
shall not be held liable for any failure to perform

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       16

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

any obligations under this Agreement (x) that have been transitioned by the CBOT
to a Person other than LIFFE, or (y) that have been wound down or phased out;
and (ii) in the event of the CBOT's breach of any of its material obligations
under this Agreement during any Transition Period, then LIFFE may terminate this
Agreement immediately upon notice to the CBOT.

     12.4 Survival. The termination of this Agreement for any reason will not
affect the accrued rights of the Parties or the right of either Party to sue for
damages arising from a breach of this Agreement. Notwithstanding termination of
this Agreement, the CBOT shall remain liable to pay LIFFE all sums accrued or
due on or prior to the effective date of termination. Sections 1, 5.2, 6.5, 8,
9, 12, 13, 14, 16.3, 17, 18, 19, 21, 22, 24, 27, 28, 29, 30, 32 and 34 shall
survive beyond the effective date of termination of this Agreement and shall
remain in full force and effect.

13.  Proprietary Rights

     13.1 LIFFE Property. As between the CBOT and LIFFE, all rights, title and
interest in and to the Licensed Technology and all portions thereof (excluding
the third party software specified in Schedule G), including but not limited to,
all Development Services Deliverables; all Upgrades (including Bug Fixes created
by or on behalf of the CBOT pursuant to Section 7.1(d)); all Confidential
Information of LIFFE; all Documentation; the Equipment; all other materials
whatsoever relating to the Licensed Technology and provided by LIFFE to the CBOT
and/or any Sublicensees, including any gateways, hubs, routers, cables, cabinets
and servers; and any other materials provided by LIFFE to the CBOT and/or any
Sublicensees under this Agreement; including all copyrights, trademarks,
patents, trade secrets and other intellectual property inherent in the foregoing
or appurtenant thereto (collectively, "LIFFE Property") shall be and remain
vested in LIFFE (or LIFFE's Affiliates, suppliers or licensors, as applicable).
To the extent, if any, that ownership of the LIFFE Property does not
automatically vest in LIFFE by virtue of this Agreement or otherwise, the CBOT
hereby transfers and assigns to LIFFE, as of the date of creation, all rights,
title and interest which the CBOT may have in and to such LIFFE Property. The
CBOT undertakes, at the CBOT's expense, to do or cease to do all such acts as
LIFFE may reasonably direct, and to execute, or cause its employees, agents
and/or subcontractors to execute, all such documents as LIFFE deems reasonably
necessary or helpful to assure further the rights, title and interest of LIFFE
or its nominee in and to such LIFFE Property.

     13.2 CBOT's Property. Notwithstanding the foregoing, as between the CBOT
and LIFFE, all rights, title and interest in and to (a) the CBOT Technology (if
any); (b) Market Data (collectively, the "CBOT's Property") shall be and remain
vested in the CBOT; (c) all Confidential Information of the CBOT; and (d) all
copyrights, trademarks, patents, trade secrets and other intellectual property
inherent in the foregoing or appurtenant thereto.

14.  Confidentiality

     14.1 Confidential Information. Subject to Section 14.2, each Party shall
treat as confidential the terms and conditions of this Agreement (excluding the
existence of this Agreement), all information (a) marked as confidential, "CBOT
Restricted" and/or "LIFFE Restricted" (as applicable) or (b) which the recipient
should reasonably know, by its nature or the manner of its disclosure, to be
confidential (including, but not limited to, the information and materials the
CBOT has obtained rights to use hereunder), which either Party may receive or
have access to during or prior to the performance of this Agreement
("Confidential Information"). Neither Party shall (i) use the Confidential
Information of the other Party for any purpose other than the performance of its
obligations under this Agreement, or (ii) divulge such Confidential Information
(x) without the other Party's prior written consent, to anyone other than the
employees, subcontractors, consultants or advisors of such Party who are subject
to

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       17

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

nondisclosure obligations and to whom such disclosure is reasonably necessary to
facilitate the performance of this Agreement; or (y) unless requested pursuant
to a judicial or governmental request, requirement or order under law (including
disclosure obligations of the Parties under applicable securities laws), in
which case, if not so prohibited by a regulatory or other governmental authority
or an order of a court of competent jurisdiction, the receiving Party will
promptly notify the other Party of such request; provided that, if, in the
opinion of counsel to the receiving Party, such disclosure is required under
securities laws, the receiving Party, in consultation with the other Party,
shall additionally use good faith efforts to secure confidential treatment of
the information so disclosed. "Confidential Information" of LIFFE includes, but
is not limited to, Restricted Documentation and the source code of the Software.
For the avoidance of doubt, with respect to Confidential Information of LIFFE
that has been disclosed to the CBOT or to which the CBOT has access, the CBOT
shall neither provide or permit [**] access to, nor permit any other Person to
provide or permit [**] access to, any Confidential Information of LIFFE or any
derivative work based on such Confidential Information.

     14.2 Exclusions. Notwithstanding Section 14.1, Confidential Information
will not include information (a) which is independently developed by the
receiving Party or is lawfully received free of restriction from another source
that, to the receiving Party's knowledge, has the right to furnish such
information; (b) after it has become generally available to the public by acts
not attributable to the receiving Party or its employees, consultants or
advisors; or (c) which, at the time of disclosure to the receiving Party, was
known to the receiving Party free of restriction.

15.  Subcontractors

     LIFFE may appoint subcontractors and agents to carry out the whole or any
part of its obligations hereunder; provided, however, that LIFFE shall obtain
the CBOT's consent to any subcontractors whose primary residence is located in
the United States, which consent will not be unreasonably withheld. For the
avoidance of any doubt, LIFFE shall not have an obligation to obtain the CBOT's
consent in respect of any subcontractors whose primary residence is located to
LIFFE's knowledge, outside the United States.

16.  Warranties

     16.1 LIFFE. LIFFE warrants that (a) it has the requisite corporate power
and authority to execute and perform this Agreement; (b) its execution and
performance of its obligations hereunder will not violate any other agreement or
regulatory obligation to which it is bound; and (c) to LIFFE's knowledge, the
Software contains no Malicious Code. EXCEPT AS SPECIFICALLY PROVIDED IN THIS
AGREEMENT, LIFFE MAKES NO, AND HEREBY DISCLAIMS ALL, WARRANTIES, CONDITIONS,
UNDERTAKINGS, TERMS OR REPRESENTATIONS, EXPRESSED OR IMPLIED BY STATUTE, COMMON
LAW OR OTHERWISE, IN RELATION TO THE LICENSED TECHNOLOGY OR ANY PORTION OF THE
SAME OR THE USE THEREOF, INCLUDING BUT NOT LIMITED TO ALL IMPLIED WARRANTIES OF
MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NON-INFRINGEMENT. LIFFE
FURTHER DISCLAIMS ALL WARRANTIES, IMPLIED OR OTHERWISE, RELATING TO ANY THIRD
PARTY MATERIALS.

     16.2 The CBOT. The CBOT hereby warrants to LIFFE that (a) it has the
requisite corporate power and authority to execute and perform this Agreement;
(b) its execution and performance of its obligations hereunder will not violate
any other agreement or regulatory obligation to which it is bound; (c) it is a
valid licensee of the Wagner/eSpeed Patent pursuant to Attachment B to that
certain "Settlement Agreement" between the CBOT, The Chicago Mercantile
Exchange, Electronic Trading Systems Corporation and eSpeed, entered into as of
August 26, 2002, in settlement of eSpeed, Inc. and Electronic Trading Systems
Corporation v. The Board of Trade of the City of Chicago and The Chicago
Mercantile

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       18

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

Exchange, before the United States District Court for the Northern District of
Texas (Civil Action No. 3:99-CV-1016-M) (the "Wagner License"), a copy of which
has been provided to LIFFE; and (d) the License, the Licensed Technology
provided hereunder, and the use of such Licensed Technology by or on behalf of
the CBOT and Sublicensees, are encompassed by such Wagner License and will not
violate the terms of the Wagner License. EXCEPT AS SPECIFICALLY PROVIDED IN THIS
AGREEMENT, THE CBOT MAKES NO, AND HEREBY DISCLAIMS ALL, WARRANTIES, CONDITIONS,
UNDERTAKINGS, TERMS OR REPRESENTATIONS, EXPRESSED OR IMPLIED BY STATUTE, COMMON
LAW OR OTHERWISE, IN RELATION TO THE LICENSED TECHNOLOGY AND CBOT PROPERTY OR
ANY PORTION OF THE SAME OR THE USE THEREOF, INCLUDING BUT NOT LIMITED TO ALL
IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND
NON-INFRINGEMENT.

17.  Indemnification

     17.1 By LIFFE. LIFFE shall defend, indemnify and hold the CBOT, and the
officers, directors, employees, agents, and representatives of the CBOT ("CBOT
Indemnitees") harmless from and against all costs, claims, demands, losses,
expenses and liabilities of any nature whatsoever (including reasonable
attorneys fees) ("Losses") incurred or suffered by such CBOT Indemnitees arising
out of, or in connection with, any third party claim, demand, or cause of action
(each, a "Claim") to the extent such Claim is based upon or arises out of (a)
LIFFE's gross negligence or willful misconduct; (b) LIFFE's material breach of
this Agreement or any part hereof; or (c) [**]; provided that (i) the CBOT shall
take no other action which the CBOT, in its reasonable judgment, believes would
be contrary to LIFFE's interests relative to the Claim; (ii) LIFFE (or any
Person acting on behalf of or authorized by LIFFE), at its own expense, shall be
entitled to have sole conduct and control of all legal proceedings in connection
with the Claim or the settlement or other compromise thereof; (iii) the CBOT
shall give LIFFE (and any Person acting on behalf of or authorized by LIFFE) all
reasonable assistance therewith, at LIFFE's reasonable expense; and (iv) the
CBOT shall use good faith efforts to notify LIFFE as soon as possible, but in
any event within five (5) Business Days, after the CBOT becomes aware of the
Claim. Notwithstanding the foregoing, LIFFE shall have no obligation to defend,
indemnify, or hold any CBOT Indemnitee harmless from or against any Losses
incurred or suffered by such CBOT Indemnitee (x) as a result of the gross
negligence or willful misconduct of the CBOT Indemnitee or any Sublicensee, or
(y) to the extent any Losses are attributable to the fact that the use of the
Licensed Technology by the CBOT, other CBOT Indemnitee, or any Sublicensee has
not been in accordance with this Agreement.

     17.2 By the CBOT. The CBOT shall defend, indemnify and hold LIFFE, its
Affiliates, and the officers, directors, employees, agents, and representatives
of LIFFE and its Affiliates ("LIFFE Indemnitees") harmless from and against all
Losses incurred or suffered by such LIFFE Indemnitees arising out of, or in
connection with, any third party Claim to the extent such Claim is based upon or
arises out of: (a) the CBOT's material breach of this Agreement or any part
hereof; (b) the gross negligence or willful misconduct of the CBOT, any of its
Affiliates, or any Members or other Sublicensees; (c) the CBOT's Property or
LIFFE's use thereof; (d) the CBOT's use of the Licensed Technology in
contravention of this Agreement; (e) any breach by any Member, other
Sublicensee, or Contractor (as that term is defined Schedule E) of any Interface
Sublicense Agreement; or (f) any Claim that the License, the Licensed Technology
provided hereunder, or the use thereof by or on behalf of the CBOT or
Sublicensees, infringes or otherwise violates the Wagner/eSpeed Patent; provided
that (i) LIFFE shall take no action which LIFFE, in its reasonable judgment,
believes would be contrary to the CBOT's interests relative to the Claim; (ii)
the CBOT (or any Person acting on behalf of or authorized by the CBOT), at its
own expense, shall be entitled to have sole conduct and control of all legal
proceedings

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       19

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

in connection with the Claim or the settlement or other compromise thereof;
(iii) LIFFE shall give the CBOT (and any Person acting on behalf of or
authorized by the CBOT) all reasonable assistance in connection therewith at the
CBOT's reasonable expense; and (iv) LIFFE shall use good faith efforts to notify
the CBOT as soon as possible, but in any event within five (5) Business Days,
after LIFFE becomes aware of the Claim. Notwithstanding the foregoing, CBOT
shall have no obligation to defend, indemnify, or hold any LIFFE Indemnitee
harmless from or against any Losses incurred or suffered by such LIFFE
Indemnitee as a result of the gross negligence or willful misconduct of the
LIFFE Indemnitee.

18.  Liability

     18.1 Specific Limitations. LIFFE shall have no liability to the CBOT for
any breach of this Agreement or any Losses (including, but not limited to, the
CBOT's inability to use any part of the Licensed Technology and the interruption
or corruption of any data or information stored, used, generated or transmitted
on or via any Licensed Technology) under this Agreement arising from (a) any
defect in the Licensed Technology of which LIFFE has not received notice of from
the CBOT within five (5) Business Days following the first date upon which the
CBOT discovered or otherwise became aware of such defect, (b) any Force Majeure
Event, or (c) any Trading Applications or other Third Party Materials.

     18.2 General Limitation. EXCEPT AS EXPRESSLY PROVIDED IN THIS AGREEMENT,
NEITHER PARTY SHALL HAVE LIABILITY TO THE OTHER FOR ANY LOSS, DAMAGE OR INJURY,
DIRECT OR INDIRECT, WHETHER OR NOT CAUSED BY THE NEGLIGENCE OF SUCH PARTY, ITS
AFFILIATES, OR THE OFFICERS, EMPLOYEES, AGENTS OR REPRESENTATIVES OF SUCH PARTY
OR OF ANY OF ITS AFFILIATES, EXCEPT THAT EACH PARTY SHALL ACCEPT LIABILITY FOR
(a) MATERIAL BREACH OF THIS AGREEMENT, (b) THE GROSS NEGLIGENCe OR WILLFUL
MISCONDUCT OF SUCH PARTY, ITS AFFILIATES OR THE OFFICERS, EMPLOYEES, AGENTS OR
REPRESENTATIVES OF SUCH PARTY OR OF ANY OF ITS AFFILIATES, AND (c) FOR DEATH,
PERSONAL INJURY AND DIRECT PHYSICAL DAMAGE TO THE TANGIBLE PROPERTY OF THE OTHER
CAUSED BY SUCH PARTY, ITS AFFILIATES OR THE OFFICERS, EMPLOYEES, AGENTS OR
REPRESENTATIVES OF SUCH PARTY OR OF ANY OF ITS AFFILIATES. EXCEPT WITH REGARD TO
EITHER PARTY'S BREACH OF ITS CONFIDENTIALITY OBLIGATIONS UNDER SECTION 14 OR ITS
WARRANTIES SET FORTH IN SECTION 16, NEITHER PARTY SHALL BE LIABLE TO THE OTHER
HEREUNDER FOR ANY INDIRECT OR CONSEQUENTIAL LOSS, OR FOR LOSS OF PROFITS,
GOODWILL OR CONTRACTS, WHETHER ARISING FROM NEGLIGENCE, BREACH OF CONTRACT OR
OTHERWISE, AND WHETHER OR NOT EITHER PARTY SHALL HAVE BEEN ADVISED OF OR
OTHERWISE MIGHT HAVE ANTICIPATED THE POSSIBILITY OF SUCH DAMAGES.

     18.3 Limitation of Liability. The cumulative liability of LIFFE under this
Agreement, the Development Services Agreement and the Managed Services
Agreement, during the respective terms of this Agreement, the Development
Services Agreement and the Managed Services Agreement, however arising, will not
exceed [**] provided, however, that the limitations set forth in this Section
18.3 will not apply to (a) liability of LIFFE for death or personal injury; (b)
fraudulent acts or omissions; or (c) violations of the confidentiality
obligations of Section 14.

     18.4 Claims Against Individuals. Where the liability of a Party (including,
but not limited to, any liability with respect to the officers, employees,
agents or representatives of a Party or any of its Affiliates) has been excluded
or restricted hereunder, each Party agrees that it shall not bring any claim
against any officers, employees, agents or representatives of the other Party or
any of its Affiliates or join

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       20

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

such officers, employees, agents or representatives in any claim such that the
liability of such officers, employees, agents or representatives and such other
Party, when taken together, would be greater than the liability of such other
Party hereunder.

19.  Dispute Resolution

     19.1 Escalation. As used herein, "Disputes" means any claims, disputes,
controversies, and other matters in question between the Parties arising out of
or relating to this Agreement or the breach hereof (excluding any third party
claims against LIFFE or the CBOT subject to indemnification pursuant to Section
17, but including any disagreements as to indemnification rights hereunder). Any
Dispute between the Parties shall in the first instance be referred to the
Parties' Relationship Managers for discussion and resolution. If the Dispute is
not resolved by the Relationship Managers within five (5) Business Days, the
Dispute will be referred to the Managing Director of LIFFE Market Solutions and
a representative of the CBOT at an equivalent level, who must discuss and, if
appropriate, meet within five (5) Business Days to attempt to resolve the
Dispute. If the Dispute is not resolved by such second representatives within
five (5) Business Days, the Dispute will be referred to the Parties' Chief
Executive Officers who must discuss and, if appropriate, meet within five (5)
Business Days to attempt to resolve the Dispute. If any representative of either
Party referred to in this Section 19.1 is not available for any reason, the
affected Party shall be entitled to appoint an appropriate substitute.

     19.2 Mediation. If the Parties cannot resolve any Dispute in accordance
with Section 19.1 within thirty (30) Business Days, they may refer the Dispute
to mediation, to be conducted by a single mediator in (i) Chicago, Illinois, if
LIFFE has initiated the Dispute, or (ii) London, England, if the CBOT has
initiated the Dispute. The Parties shall use good faith efforts to agree upon a
mediator. If the Parties are unable to agree upon a mediator within thirty (30)
Business Days, the Parties may seek judicial resolution and remedy of the
Dispute without first proceeding with mediation. The Parties shall use good
faith efforts to hold the mediation within thirty (30) Business Days following
the selection of a mediator. Unless otherwise agreed by the Parties, no decision
resulting from the mediation proceedings will be binding upon the Parties.
Unless expressly provided herein, each Party will bear its own costs (including
attorneys fees) relating to the mediation, but the Parties will share equally
the fees and expenses charged by the mediator.

     19.3 Arbitration. If a Dispute is not resolved in accordance with Section
19.2, then either Party may provide written notice to the other Party of an
intention to refer the Dispute to arbitration. Any such arbitration shall be:
(a) binding; (b) administered by the International Centre for Dispute Resolution
("ICDR") of the American Arbitration Association ("AAA"); (c) conducted in
accordance with the International Arbitration Rules of the AAA (the "AAA
Rules"), as such AAA Rules may be amended from time to time, except to the
extent this Section 19.3 provides otherwise; (d) held in Chicago, Illinois, if
the Dispute is initiated by LIFFE and in London, England if the Dispute is
initiated by the CBOT; and (e) conducted using the English language. Upon filing
a claim, the filing Party will simultaneously provide written notice of such
claim to the other Party and to the relevant administrator at the ICDR.

          19.3.1 Selection of Arbitrators. Within ten (10) Business Days of
                 receipt of the ICDR initiation letter, each Party shall select
                 one neutral individual to act as arbitrator. In addition, the
                 Parties shall submit a written request to AAA to use its normal
                 procedures pursuant to the AAA Rules to appoint the third
                 arbitrator within five (5) Business Days of AAA's receipt of
                 such request. The arbitrator appointed by AAA shall serve as
                 the chairperson of the arbitration panel. The Parties agree
                 that the selection of arbitrators must be completed within
                 twenty-five (25) Business Days of receipt by both Parties of
                 the ICDR initiation letter.

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       21

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

          19.3.2 Cooperation. The Parties shall cooperate with each other in
                 causing the arbitration to be held in as efficient and
                 expeditious a manner as practicable, and in this respect to
                 furnish such documents and make available such personnel as the
                 arbitrators may request.

          19.3.3 Reduction of Losses. The Parties have selected arbitration to
                 expedite the resolution of Disputes and to reduce the costs
                 and burdens associated with litigation. The Parties agree
                 that the arbitrators should take these concerns into account
                 when determining whether to authorize discovery and, if
                 discovery is authorized, the scope of permissible discovery
                 and other hearing and pre-hearing procedures. Thearbitrators
                 shall render an award, including a written decision, within
                 ninety (90) calendar days after the arbitration notice is
                 provided, unless the Parties otherwise agree or the arbitrators
                 make a finding that a Party has carried the burden of showing
                 good cause for a longer time period.

          19.3.4 Binding Decision. The decision or award of the arbitrators will
                 be final and binding, and may be used as a basis for judgment
                 thereon in any jurisdiction. The award shall be in writing,
                 shall be signed by a majority of the arbitrators, and shall
                 include a written decision setting out the reasons for the
                 disposition of any claim.

          19.3.5 Punitive Damages. Without limiting any other remedies that may
                 be available under applicable law, the arbitrators shall have
                 no authority to award punitive damages.

          19.3.6 Confidentiality. All proceedings and decisions of the
                 arbitrators shall be maintained in confidence to the extent
                 legally permissible, and shall not be made public by any Party
                 or any arbitrator without the prior written consent of the
                 Parties, except as may be required by applicable laws.

          19.3.7 Losses. Each Party shall bear its own costs and attorneys fees,
                 and the Parties shall equally bear the fees, costs, and
                 expenses of the arbitrators and the arbitration proceedings
                 charged by the arbitrators ("Arbitration Fees"); provided,
                 however, that (a) the filing Party shall pay any filing fees
                 charged by the AAA; and (b) the arbitrators may exercise
                 discretion to award costs, but not attorneys fees or
                 Arbitration Fees, to the prevailing Party.

          19.3.8 Obligations. The commencement and pendency of an arbitration
                 under this Section 19.3 shall not relieve either of the Parties
                 of their respective obligations under this Agreement.

          19.3.9 Limitations. A demand for arbitration shall not be made after
                 the date when institution of legal or equitable proceedings
                 based upon such dispute would be barred by the applicable
                 statute of limitations or laches under the laws of the State
                 of Illinois, and the Parties expressly waive any causes of
                 action relating to any Dispute not brought within the period
                 set forth therein.

     19.4 Limitations. Notwithstanding Sections 19.2 and 19.3, nothing herein
restricts the rights of either Party to seek judicial resolution and remedy of
(i) any Disputes, following compliance with

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       22

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

Section 19.2 and 19.3, or (ii) any claims, disputes, controversies, or other
matters in question between the Parties arising out of either Party's breach of
its obligations pursuant to Section 14 or Section 16.

20.  Reasonable Efforts

     Each Party agrees to use good faith efforts to negotiate the Development
Services Agreement and the Managed Services Agreement. LIFFE shall deliver to
the CBOT a draft (a) Development Services Agreement, by [**] and (b) Management
Services Agreement, by [**]

21.  Entire Agreement

     This Agreement, together with any Development Services Agreement and
Managed Services Agreement entered into by the Parties, constitutes the entire
understanding between the Parties with respect to the subject matter hereof and
supersedes all prior representations, agreements, negotiations and discussions
between the Parties, excluding that Consultancy Agreement entered into by and
between LIFFE and the CBOT, having an effective date of October 22, 2002, and
entered into on December 6, 2002.

22.  Schedules

     Each of the schedules attached hereto is a part of and incorporated into
this Agreement. Unless otherwise indicated therein, all capitalized terms
contained within the Schedules will have the meanings ascribed to them in the
main body of this Agreement.

23.  Amendments

     Except as expressly provided for herein, this Agreement may be amended only
by an instrument in writing signed on behalf of a duly authorized representative
of each Party.

24.  Binding Provisions/Third Party Beneficiaries

     This Agreement is binding upon, and shall inure to the benefit of, the
Parties and their respective administrators, legal representatives, successors,
and permitted assigns. The Parties agree that no provision of this Agreement is
intended, expressly or by implication, to purport to confer a benefit or right
of action upon a third party (whether or not in existence, and whether or not
named, as of the Effective Date).

25.  Assignment and Sublicensing

     Except as otherwise expressly provided herein, the CBOT shall not assign,
transfer or sublicense any right or obligation under this Agreement without the
prior written approval of LIFFE; provided however, that the CBOT may assign its
rights and obligations under this Agreement to CBOT Holdings, Inc. ("Holdings")
or to a wholly owned exchange subsidiary of Holdings, as described in the
Registration Statement on Form S-4 filed by Holdings with the Securities and
Exchange Commission ("SEC") on October 24, 2001 (the "Registration Statement"),
as amended by Amendment No. 4 to the Registration Statement filed with the SEC
on December 30, 2002 ("Amendment No. 4"), or any subsequent amendment thereto,
provided that the structure of the exchange subsidiary is in a form
substantially the same as that described in Amendment No. 4. LIFFE may, in
LIFFE's sole discretion, assign this Agreement and/or its rights and obligations
under this Agreement to an Affiliate of LIFFE that is capable of performing the
obligations of LIFFE under this Agreement.

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       23

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

26.  Force Majeure

     If the performance of this Agreement by either Party is prevented,
hindered, delayed or otherwise made impracticable by reason of any Force Majeure
Event, that Party shall be excused from such performance to the extent that it
is prevented, hindered or delayed by such cause. In the event a Party becomes
aware of a Force Majeure Event that will affect its performance under this
Agreement, it shall notify the other Party as soon as reasonably practicable.
The Parties shall thereafter work together to take reasonable steps to mitigate
the effects of any inability to perform, if practicable.

27.  Separability of Provisions

     Each provision of this Agreement shall be considered separable; and if, for
any reason, any provision of this Agreement is determined by a court of
competent jurisdiction to be invalid, unlawful, or unenforceable, such
determination shall not affect the enforceability of the remainder of this
Agreement or the validity, lawfulness, or enforceability of such provision in
any other jurisdiction.

28.  Waiver

     The failure of a Party to exercise or enforce any right conferred upon it
by this Agreement shall not be deemed to be a waiver of any such right or
operate so as to bar the exercise or enforcement thereof at any time or times
hereafter.

29.  Remedies Not Exclusive

     No remedy conferred by any provision of this Agreement is intended to be
exclusive of any other remedy, except as expressly provided in this Agreement,
and each and every remedy shall be cumulative and shall be in addition to every
other remedy given hereunder or now or hereafter existing in law or in equity or
by statute or otherwise.

30.  Notices

     Except as otherwise expressly provided herein, all notices, certifications,
requests, demands, payments and other communications hereunder: (a) shall be in
writing; (b) may be delivered by certified or registered mail, postage prepaid;
by hand; by facsimile; or by any internationally recognized private courier; (c)
shall be effective (i) if mailed, on the date ten (10) days after the date of
mailing or (ii) if hand delivered, faxed, or delivered by private courier, on
the date of delivery; and (d) shall be addressed as follows:

               If to the CBOT:

               Board of Trade of the City of Chicago, Inc.
               141 West Jackson Boulevard
               Suite 600-A
               Chicago, Illinois 60604  U.S.A.
               Attention: Carol A. Burke

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       24

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

               If to LIFFE:

               LIFFE Administration and Management
               Cannon Bridge House
               1 Cousin Lane
               London, EC4R 3XX  (England)
               Attention:  Company Secretary

or to such other address or addresses as may hereafter be specified by notice
given by one Party to the other.

31.  Announcements

     Neither Party may refer to this Agreement in any publicity or advertising
materials without the other Party's prior written consent.

32.  Interpretation

     32.1 Headings, Gender, "Including," "Control" and Person. References to
sections and schedules are to sections of and schedules to this Agreement unless
otherwise indicated. Section headings are inserted for convenience of reference
only and shall not affect the construction of this Agreement. The masculine
gender shall include the feminine and the singular number shall include the
plural, and vice versa. Any use of the word "including" will be interpreted to
mean "including, but not limited to," unless otherwise indicated. Any use of the
terms "controlling," "controlled by" or "under common control with" shall have a
meaning consistent with the definition of "Control" set forth in Section 1.
References to any Person (including the Parties and any other entities referred
to) shall be construed to mean such Person and its successors in interest and
permitted assigns, as applicable.

     32.2 Inconsistency. In the event of any inconsistency between the terms of
the main body of this Agreement and any schedule hereto, the terms of the main
body of this Agreement will govern to the extent of the inconsistency.

33.  Further Assurances

     The Parties shall execute all such further documents and do all such
further acts as may be necessary to carry the provisions of this Agreement into
full force and effect.

34.  Governing Law

     The validity and effectiveness of this Agreement shall be governed by and
construed and enforced in accordance with the internal laws of the State of
Illinois, without giving effect to the provisions, policies or principles of any
state law relating to choice or conflict of laws. Subject to Section 19, any
legal action or proceeding with respect to this Agreement may be brought
exclusively in the Federal or state courts located in Chicago, Illinois,
including the United States District Court for the Northern District of
Illinois. The United Nations Convention on Contracts for the International Sale
of Goods shall not apply to this Agreement and is hereby disclaimed.

35.  Counterparts

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       25

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

     This Agreement may be executed in two counterparts, each of which when so
executed and delivered shall be deemed an original, and both of which together
shall constitute but one and the same instrument.

                  [Remainder of page intentionally left blank.
                             Signature page follows]

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       26

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

     IN WITNESS WHEREOF, the Parties have executed this Software License
Agreement as of the Effective Date.

                                     LIFFE ADMINISTRATION AND MANAGEMENT, a
                                     company incorporated in England and Wales

                                     By:   /s/ Mark S. Hemsley
                                         -------------------------------------
                                     Name: Mark S. Hemsley
                                         -------------------------------------
                                     Its:  Director
                                         -------------------------------------

                                    BOARD OF TRADE OF THE CITY OF CHICAGO, INC.,
                                    a Delaware corporation

                                     By:   /s/ Bernard W. Dan
                                         ---------------------------------------
                                     Name: Bernard W. Dan
                                         ---------------------------------------
                                     Its:  President and Chief Executive Officer
                                         ---------------------------------------

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

                                    SCHEDULES

Schedule A   -   Software and Documentation

Schedule B   -   Software, Locations and Operating Systems

Schedule C   -   Products Outside CBOT Field of Use

Schedule D   -   Products Within CBOT Exclusive Field of Use

Schedule E   -   Interface Sublicense Agreement

Schedule F   -   Security Policy

Schedule G   -   Third Party Software

Schedule H   -   Escrow Agreement

Schedule I   -   Fees

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

                                   SCHEDULE A

                           SOFTWARE AND DOCUMENTATION
                           --------------------------

     Part 1 - Software

     [**]

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

     Part 2 - Documentation
              -------------

     (a)  Unrestricted Documentation

          1.   LIFFE CONNECT(TM) Application Program Interface and Changes

          2.   The Application Program Interface Reference Manual

          3.   LIFFE CONNECT(TM) Release Specific Information - The Application
               Program Interface Reference Manual

          4.   LIFFE CONNECT(TM) Application Program Interface Installation
               notes

          5.   How the Market Works

          6.   TRS User Guide

     (b)  Restricted Documentation
          ------------------------
<TABLE>
<CAPTION>
     ------------------------------------------------------------------------------------------------------------
                                                                                         Number of
                                            Title                                    Authorized Copies
     ------------------------------------------------------------------------------------------------------------
     <S>                                    <C>                                      <C>
     1.                                      [**]                                           [**]
     ------------------------------------------------------------------------------------------------------------
     2.                                      [**]                                           [**]
     ------------------------------------------------------------------------------------------------------------
     3.                                      [**]                                           [**]
     ------------------------------------------------------------------------------------------------------------
     4.                                      [**]                                           [**]
     ------------------------------------------------------------------------------------------------------------
     5.                                      [**]                                           [**]
     ------------------------------------------------------------------------------------------------------------
     6.                                      [**]                                           [**]
     ------------------------------------------------------------------------------------------------------------
     7.                                      [**]                                           [**]
     ------------------------------------------------------------------------------------------------------------
     8.                                      [**]                                           [**]
     ------------------------------------------------------------------------------------------------------------
     9.                                      [**]                                           [**]
     ------------------------------------------------------------------------------------------------------------
     10.                                     [**]                                           [**]
     ------------------------------------------------------------------------------------------------------------
     11.                                     [**]                                           [**]
     ------------------------------------------------------------------------------------------------------------
     12.                                     [**]                                           [**]
     ------------------------------------------------------------------------------------------------------------
</TABLE>

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

                                   SCHEDULE B

                     SOFTWARE, LOCATIONS & OPERATING SYSTEMS
                     ---------------------------------------

<TABLE>
<CAPTION>
------------------------------------------------------------------------------------------------------------
                                                            Operating System (or such operating systems as
          Software                     Location              may be approved by LIFFE from time to time)
============================================================================================================
          <S>                          <C>                  <C>
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
</TABLE>

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

<TABLE>
<CAPTION>
------------------------------------------------------------------------------------------------------------
                                                            Operating System (or such operating systems as
          Software                     Location              may be approved by LIFFE from time to time)
============================================================================================================
          <S>                          <C>                  <C>
            [**]                         [**]                          [**]
------------------------------------------------------------------------------------------------------------
</TABLE>

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

                                   SCHEDULE C

                       PRODUCTS OUTSIDE CBOT FIELD OF USE
                       ----------------------------------

<TABLE>
---------------------------------------------------------------------------------------------------------
<S>                           <C>                                      <C>
 Index Futures                Short Term Interest Rate Futures         Commodity Futures
---------------------------------------------------------------------------------------------------------
      [**]                          [**]                                     [**]
                             ------------------------------------
                              Short Term Interest Rate Options

                                    [**]
---------------------------------------------------------------------------------------------------------
 Index Options                Medium and Long Term Interest Rate       Commodity Options
                              Futures
---------------------------------------------------------------------------------------------------------
      [**]                          [**]                                     [**]

---------------------------------------------------------------------------------------------------------
                              Medium and Long Term Interest Rate       Other Products
                              Options
---------------------------------------------------------------------------------------------------------
                                    [**]                               Futures

                                                                       [**]

                                                                       Options

                                                                       [**]

---------------------------------------------------------------------------------------------------------
</TABLE>

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

                                   SCHEDULE D

                   PRODUCTS WITHIN CBOT EXCLUSIVE FIELD OF USE
                   -------------------------------------------

<TABLE>
-------------------------------------------------------------------------------------------------
<S>             <C>                        <C>                            <C>
Agricultural    Treasury Futures           Treasury Options               Index Futures
Futures
-------------------------------------------------------------------------------------------------
        [**]            [**]                       [**]                           [**]
-------------------------------------------------------------------------------------------------
Agricultural    Federal Funds Futures      Other Financial Options        Index Options
Options
-------------------------------------------------------------------------------------------------
        [**]            [**]                       [**]                           [**]
-------------------------------------------------------------------------------------------------
                Other Financial Futures    Metal Options
-------------------------------------------------------------------------------------------------
                        [**]                       [**]
-------------------------------------------------------------------------------------------------
                                           Metal Futures
-------------------------------------------------------------------------------------------------
                                                   [**]
-------------------------------------------------------------------------------------------------
</TABLE>

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

                                   SCHEDULE E

                         INTERFACE SUBLICENSE AGREEMENT
                         ------------------------------

     This Interface Sublicense Agreement (this "Agreement") dated as of
__________ __, 200__ (the "Effective Date"), is among Board of Trade of the City
of Chicago, Inc., a Delaware corporation (the "CBOT"), and ____________, a(n)
_________ [form of entity] ("Licensee"). Capitalized terms used but not
otherwise defined herein shall have the meanings ascribed thereto in Section 1.

                                    RECITALS

     A. The CBOT offers an automated derivatives trading and order matching
system known as "LIFFE CONNECT(TM)" (the "Trading System") to facilitate the
trading of certain futures and options contracts on the electronic contract
market operated by the CBOT (the "Exchange").

     B. In order to gain access to and participate in the Exchange via the
Trading System, Licensee wishes, and the CBOT is willing to license to Licensee
the right, to access the Interface component of the Trading System set forth in
Exhibit A which the CBOT may provide with the software (the "Software"), and to
use any documentation relating to the Software the CBOT may provide (the
"Interface Documentation" and together with the Software, the "Licensed
Products").

     In consideration of the recitals and the mutual covenants and agreements
hereinafter set forth, the parties hereto (each a "Party" and collectively the
"Parties") agree as follows:

                                   AGREEMENT

1.   Definitions

     In this Agreement, the following expressions shall have the following
     respective meanings:

     "Agreement" shall have the meaning set forth above.

     "Application" means a front-end application or other software which
     interfaces with, and has been conformed with, the Interface.

     "CBOT Matching Engine" means the central processing component of the
     Trading System.

     "CBOT Property" shall have the meaning set forth in Section 11.1.

     "Confidential Information" shall have the meaning set forth in Section
     12.1.

     "Contractor" means a Person contracted by Licensee to assist Licensee in
     developing Applications.

     "Data" means externally disseminated Exchange-related pricing and trade
     volume information.

     "Effective Date" shall have the meaning set forth above.

     "Exchange" shall have the meaning set forth above.

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

     "Exchange Notice" means a notice published by the Exchange by such means as
     the Exchange may from time to time determine.

     "Force Majeure Event" means any cause beyond a Party's reasonable control,
     including, but not limited to, any flood, riot, fire, judicial or
     governmental action, and labor disputes.

     "Interface" means the LIFFE CONNECT(TM) application interface described in
     Exhibit A for the use and/or access to the CBOT Matching Engine by an
     Application.

     "Interface Documentation" shall have the meaning set forth above.

     "Licensed Products" shall have the meaning set forth above.

     "Licensee's Property" shall have the meaning set forth in Section 11.2.

     "LIFFE" means LIFFE Administration and Management, a company incorporated
     in England and Wales, having a principal place of business at Cannon Bridge
     House, 1 Cousin Lane, London EC4R 3XX, England.

     "Malicious Code" means any computer virus, Trojan horse, worm, time bomb,
     or other similar code or hardware component designed to disrupt the
     operation of, permit unauthorized access to, erase, or modify the Licensed
     Products.

     "Member" means any Person authorized by the CBOT to trade on the Exchange.

     "Parties" shall have the meaning set forth above.

     "Person" means an individual, partnership, corporation, limited liability
     company, trust, joint venture, joint stock company, association,
     unincorporated organization, government agency or political subdivision
     thereof, or other entity.

     "Premises" means the premises specified in Exhibit A.

     "Responsible Person" means, with respect to the Trading System, an
     individual who is (i) designated as such by Licensee, if Licensee is a
     Member, pursuant to the Rules, and (ii) registered with the Exchange.

     "Rules" means the rules of the Exchange and each procedure and Exchange
     Notice as in effect from time to time and, (i) with respect to the trading
     of futures contracts, the regulations of the United States Commodity
     Futures Trading Commission (the "CFTC"); (ii) with respect to the trading
     of securities futures, the rules and regulations of the Securities and
     Exchange Commission (the "SEC") and the CFTC; and (iii) with respect to the
     trading of securities other than securities futures, the rules and
     regulations of the SEC.

     "Software" shall have the meaning set forth above.

     "Third Party Materials" means any equipment, hardware, software, or other
     products obtained from any third party.

     "Trading System" shall have the meaning set forth above.

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       2

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

     "User Guides" means the documentation which may be provided relating to the
     use of the Trading System.

2.   License

     2.1 License. Subject to the terms and conditions hereof, the CBOT hereby
grants to Licensee a non-transferable, non-exclusive and royalty-free license
(a) to, and to sublicense to one or more Contractors the right to, have
reasonable access to the Interface and use the Software and the Interface
Documentation to procure and/or develop Applications; (b) to install the
Software at the Premises; and (c) to use the Software to access Data. If
Licensee is a Member, the CBOT additionally grants to Licensee a
non-transferable and non-exclusive license to use the Interface to access the
CBOT Matching Engine and, if possible, other components of the Trading System.
Licensee may not make any other use of the Licensed Products.

     2.2 Contractors. Licensee shall ensure that each Contractor to which
Licensee sublicenses its rights (a) shall make no use of the Licensed Products
other than that set forth in Section 2.1(a), and (b) otherwise abides by the
terms of this Agreement as if Contractor were a party to this Agreement.
Licensee is responsible for all actions of each Contractor with respect to the
Licensed Products.

3.   Delivery of Licensed Products

     3.1 Software. By such date(s) as may be agreed upon by the Parties and via
a delivery method agreed upon by the Parties, the CBOT shall deliver to the
Premises a master copy of the current version of the Software, in object code
form. Licensee may copy the Software only with the prior written consent of the
CBOT. All copies of the Software are subject to the terms and conditions of this
Agreement.

     3.2 Interface Documentation. Upon Licensee's request, by such date(s) as
may be agreed upon by the Parties, and via a delivery method and in a format
agreed upon by the Parties, the CBOT will provide the Interface Documentation to
Licensee. Licensee may make as many copies of the Interface Documentation as it
deems reasonably necessary. All copies of the Interface Documentation are
subject to the terms and conditions of this Agreement.

4.   Modifications and Improvements

     CBOT reserves the right during the term of this Agreement to specify for
use and/or access hereunder any improvements, modifications, enhancements or
upgrades to and of the Licensed Products or any part or parts thereof. Unless
otherwise specified by the CBOT, Licensee shall use only the current release
version(s) of the Software provided hereunder.

5.   Obligations of Licensee

     5.1  Use of Software.

          5.1.1 General Restrictions. With respect to the Software, Licensee
                agrees not to, and not to permit any Contractor or any other
                Person to:

                (a) copy, modify, duplicate, decompile, reverse engineer,
                    disassemble or otherwise reduce to a humanly perceivable
                    form, make any attempt to discover the source code of,
                    create derivative works based on, market,

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       3

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

                    sell, provide or make available to any third party,
                    otherwise distribute, or translate the Software, except as
                    expressly provided herein;

               (b)  remove or alter in any manner any trademarks, trade names,
                    copyright notices or other proprietary or confidentiality
                    notices of the CBOT or third Persons contained or displayed
                    in or on the Software; or

               (c)  upload any Malicious Code or otherwise use the Software to
                    further any purpose which is illegal or is otherwise
                    contrary to the License.

          5.1.2 Copies. In the event that Licensee is granted permission
                pursuant to Section 3.1 to copy the Software, Licensee shall:

                (a) ensure that all trademarks, trade names, copyright notices
                    and other proprietary and confidentiality notices or
                    designations, of the CBOT or any other Person, contained or
                    displayed in or on the Software, are reproduced on all
                    Software copies created by Licensee; and

                (b) maintain a current and accurate record of the number of
                    copies made and of the specific location of each such copy.

     5.2 Use of Interface Documentation. Licensee shall ensure that all
trademarks, trade names, copyright notices and other proprietary and
confidentiality notices or designations, of the CBOT, or any other Person, are
reproduced on all Interface Documentation copies made by Licensee. Licensee
agrees not to, and not to permit any Contractor or any other Person to: (a)
copy, modify, translate, create derivative works based on, market, sell, or
distribute the Interface Documentation, except as expressly provided herein; or
(b) remove or alter in any manner any trademarks, trade names, copyright notices
or other proprietary or confidentiality notices or designations contained or
displayed therein.

     5.3 Materials and Assistance. In order to facilitate the CBOT's performance
of its obligations hereunder, Licensee shall promptly provide to the CBOT any
information, documentation, access to the Premises, equipment, software, and
personnel as the CBOT may reasonably request.

     5.4 Export Compliance. Licensee shall comply with all applicable export
laws and regulations of the United States and foreign authorities, including
regulatory authorities. For purposes of this obligation, export laws and
regulations include, but are not limited to, all applicable end use controls and
all applicable restrictions on the export, reexport and transfer of encryption
items.

6.   Market Entry Testing

     6.1 Testing Process. Prior to being permitted to participate in the
Exchange via any Application, Licensee must complete the CBOT's Market Entry
Testing process, which process is designed to safeguard the integrity of the
Exchange by verifying that (a) Licensee demonstrates an appropriate level of
technical and operational readiness to participate in the Trading System; and
(b) each Application conforms to a series of criteria to ensure it will not
cause degradation of the Trading System and is fit for the purpose of
participating in the Exchange. Upon request by Licensee, the CBOT shall provide
Licensee a test environment loaded with a dummy market and a pre-defined script
known as a "Market Entry Test" or "MET," and Licensee shall undertake the
testing process. If the CBOT deems, in its sole discretion, that Licensee and
the particular Application being tested have met all of the relevant Market
Entry Testing requirements, the CBOT will issue to Licensee, if required by the
operation of the

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       4

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

Interface, an appropriate encrypted license key (which key will be a view only
key unless Licensee is a Member) which will permit the Licensee to participate
in the Exchange utilizing the Application tested. If the CBOT determines, in its
sole discretion, that Licensee has not met all of the Market Entry Testing
requirements, the CBOT will so notify Licensee, which will then be provided a
subsequent opportunity to undertake Market Entry Testing during the time period
specified by the CBOT.

     6.2 Modified Applications. In the event any Application which has passed
the Market Entry Testing process is modified, Licensee must (a) notify the CBOT,
and (b) undertake Market Entry Testing of the modified Application.

7.   Payment

     7.1 Expenses. Licensee shall promptly reimburse the CBOT for any expenses
incurred hereunder in association with the performance of the CBOT's obligations
hereunder, including, but not limited to, all travel and travel-related
expenses.

     7.2 Late Payment. All past due amounts owed to the CBOT will earn interest
at the rate of the lesser of one and one half percent (1.5%) per month or the
maximum amount allowed under applicable law, commencing on the applicable due
date. Licensee will reimburse the CBOT for all reasonable costs (including
reasonable attorneys fees) incurred in collecting past due amounts owed by
Licensee.

     7.3 Taxes. Licensee shall pay or reimburse the CBOT for all taxes, however
designated, and whether international, national, state or local, which are
levied or imposed in connection with or as a result of this Agreement,
excluding, however, taxes based on the CBOT's net income.

8.   Term

     This Agreement shall commence on the Effective Date and shall continue
until and unless terminated in accordance with Section 9 or as otherwise
provided in this Agreement.

9.   Termination

     9.1 By the CBOT. The CBOT may terminate this Agreement for any reason,
immediately upon written notice to Licensee.

     9.2 By Licensee. Licensee may terminate this Agreement for any reason, upon
one day's written notice to the CBOT.

     9.3 Automatic Termination. This Agreement will terminate automatically upon
(a) the death of Licensee, if Licensee is an individual; or (b) the dissolution
of Licensee, if Licensee is other than an individual.

10.  Consequences of Termination

     10.1 Software. Upon termination of this Agreement, for whatever reason,
Licensee shall immediately cease access to and use of the Licensed Products and,
at Licensee's cost, shall return to the CBOT or its designee the Licensed
Products and other CBOT Property (as defined in Section 11.1) in the possession
or control of Licensee or any Contractor, including, but not limited to, any
Confidential Information (as defined in Section 12.1) of the CBOT. Licensee
shall be responsible for any damage to

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       5

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

or deterioration of the Licensed Products arising out of a breach by Licensee of
this Agreement or any negligence or willful misconduct of Licensee, any
Contractors, or the employees, officers or agents of Licensee or such
Contractors.

     10.2 Payment. Upon any termination of this Agreement, Licensee shall pay to
the CBOT any and all unpaid and outstanding amounts due hereunder through the
effective date of termination.

     10.3 Survival. The termination of this Agreement for any reason will not
affect the accrued rights of the Parties or the right of either Party to sue for
damages arising from a breach of this Agreement. Sections 1, 7, 10, 11, 12, 13,
14, 15, 16 (solely for the purpose of the repossession of the Licensed Products
upon termination), 19, 21, 23, 24, 25, 26, 27, 28 and 30 will survive the
termination of this Agreement.

11.  Proprietary Rights

     11.1 CBOT Property. As between Licensee and the CBOT, all rights, title,
and interest in and to the Licensed Products and all parts thereof; all other
materials and documentation whatsoever relating to the Licensed Products and/or
provided by the CBOT to Licensee; all Confidential Information (as defined
below) of the CBOT; Market Data; and all enhancements and upgrades to and
modifications of the Licensed Products; including all copyrights, trademarks,
and other intellectual property inherent in the foregoing or appurtenant thereto
(collectively, "CBOT Property") shall be and remain vested in the CBOT (or its
licensors, as applicable). To the extent, if any, that ownership of CBOT
Property does not automatically vest in the CBOT (or its licensors, as
appropriate) by virtue of this Agreement or otherwise, Licensee hereby agrees to
transfer and assign to the CBOT (or its licensors, as appropriate), all rights,
title, and interest which Licensee may have in and to such CBOT Property.
Licensee acknowledges that the CBOT shall have the right to provide to third
Persons technology which is the same or similar to the Licensed Products.
Licensee agrees, at its own cost, to do or cease to do all acts as the CBOT may
direct, and to execute, or cause its employees, officers, agents or Contractors
to execute, all such documents as the CBOT deems reasonably necessary or helpful
to assure further the right, title, and interest of the CBOT (or its licensors)
in and to such CBOT Property.

     11.2 Licensee's Property. As between Licensee and the CBOT, all rights,
title, and interest in and to each Application and any additional property
(other than the Licensed Products or other CBOT Property) used by Licensee
hereunder and provided by Licensee (collectively, "Licensee's Property") shall
be and remain vested in Licensee.

12.  Confidentiality

     12.1 Confidential Information. Subject to Section 12.2, each Party shall
treat as confidential all private, proprietary or confidential information
(including, but not limited to, that information and those materials Licensee
has obtained rights to use hereunder) which the CBOT and Licensee may receive or
have access to during or prior to the performance of this Agreement
("Confidential Information"), and shall not divulge such Confidential
Information: (a) to any Person other than to the employees, subcontractors,
licensors, consultants or advisors of such Party to whom such disclosure is
necessary to facilitate the performance of this Agreement, without the other
Party's prior written consent; or (b) unless requested pursuant to a judicial or
governmental request, requirement, or order under law, in which case, if not so
prohibited by a regulatory or other governmental authority or an order of a
court of competent jurisdiction, the receiving Party shall make the required
disclosure and promptly notify the other Party of such request and related
disclosure.

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       6

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

     12.2 Exclusions. Notwithstanding Section 12.1, Confidential Information
will not include information (a) which is independently developed by the
receiving Party or is lawfully received free of restriction from another source
having the right to furnish such information; (b) which has become generally
available to the public by acts not attributable to the receiving Party or its
employees, agents or contractors; or (c) which, at the time of disclosure to the
receiving Party, was known to the receiving Party free of restriction and
evidenced by documentation in the receiving Party's possession. In addition, the
CBOT shall be entitled to disclose Confidential Information of Licensee to the
Exchange, employees of the Exchange, consultants and advisors of the Exchange
and any other Person as may be necessary to facilitate the operation of the
Exchange or comply with any contractual obligations of the CBOT relating to the
operation of the Exchange.

13.  Indemnification

     Licensee shall defend, indemnify and hold the CBOT harmless, against all
costs, claims, demands, expenses and liabilities of any nature whatsoever
(including reasonable attorneys fees) incurred or suffered by the CBOT arising
out of, or in connection with, any claim, demand, or cause of action which is
based upon or arises out of: (a) the breach of this Agreement or any part
hereof; (b) use of the Licensed Products by Licensee or any Contractor in
violation of this Agreement; (c) the gross negligence or willful misconduct of
Licensee or any Contractor; (d) Licensee's Property or the CBOT's use thereof;
(e) Licensee's or Licensee's customers' use of any Application; or (e) any
damages to Licensed Products in the possession or control of Licensee or any
Contractor.

14.  Disclaimer of Warranties

     LICENSEE ACKNOWLEDGES THAT THE CBOT PROVIDES THE LICENSED PRODUCTS AND
ACCESS TO THE INTERFACE "AS IS." EXCEPT AS SPECIFICALLY PROVIDED IN THIS
AGREEMENT, THE CBOT MAKES NO, AND HEREBY DISCLAIMS ALL, WARRANTIES, CONDITIONS,
UNDERTAKINGS, TERMS OR REPRESENTATIONS, EXPRESSED OR IMPLIED BY STATUTE, COMMON
LAW OR OTHERWISE, IN RELATION TO THE LICENSED PRODUCTS OR ANY PART OR PARTS OF
THE SAME. THE CBOT SPECIFICALLY DISCLAIMS ALL IMPLIED WARRANTIES OF
MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NON-INFRINGEMENT. THE CBOT
FURTHER DISCLAIMS ALL WARRANTIES, IMPLIED OR OTHERWISE, RELATING TO ANY THIRD
PARTY MATERIALS.

15.  Liability

     15.1 General Limitation. NEITHER THE CBOT NOR ANY OFFICERS, EMPLOYEES,
AGENTS, SUBCONTRACTORS OR LICENSORS OF THE CBOT SHALL HAVE ANY LIABILITY TO
LICENSEE, OR ANY OTHER PERSON, FOR ANY LOSS, DAMAGE OR INJURY, DIRECT OR
INDIRECT (INCLUDING, BUT NOT LIMITED TO, CONSEQUENTIAL DAMAGES AND LOSS OF
PROFITS, GOODWILL OR CONTRACTS), WHETHER ARISING FROM THE NEGLIGENCE OR BREACH
OF CONTRACT OF THE CBOT, ITS OFFICERS, EMPLOYEES, AGENTS OR REPRESENTATIVES OR
OTHERWISE, AND WHETHER OR NOT EITHER PARTY (OR ANY DESIGNEE) SHALL HAVE BEEN
ADVISED OF OR OTHERWISE MIGHT HAVE ANTICIPATED THE POSSIBILITY OF SUCH DAMAGES,
EXCEPT THAT THE CBOT SHALL ACCEPT LIABILITY FOR THE GROSS NEGLIGENCE OR WILLFUL
MISCONDUCT OF THE CBOT OR ITS OFFICERS, EMPLOYEES, AGENTS, SUBCONTRACTORS OR
LICENSORS.

     15.2 Aggregate Liability. In the event of (a) liability for direct physical
damage to the tangible property of Licensee or (b) that the limitation under
Section 15.1 is found by a court of competent

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       7

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

jurisdiction to be invalid, unlawful, or unenforceable, the entire aggregate
liability of the CBOT under or in connection with this Agreement will not exceed
$500.

16.  Inspection and Disablement of the Licensed Products

     The CBOT shall be entitled, and Licensee shall permit the CBOT, to have
access to the Premises and the Licensed Products on the Premises during normal
business hours to inspect, disable or repossess such Licensed Products or any
part or parts thereof and/or to take such other action in connection with the
Licensed Products as may be deemed desirable or necessary by the CBOT:

          (a)  to determine whether Licensee is complying or has complied with
               its obligations under this Agreement;

          (b)  to facilitate efforts to remedy any defect or error in the
               Licensed Products or any part or parts thereof; or

          (c)  in the event Licensee commits a material breach of its
               obligations under this Agreement.

     Notwithstanding the foregoing, (i) the CBOT shall be entitled to prohibit
Licensee's access to the Licensed Products, to disable the Licensed Products, or
to remove the Licensed Products from the Premises at any time and from time to
time, provided that the CBOT shall, where practicable, use commercially
reasonable efforts to give prior written notice to Licensee; and (ii) unless any
such repossession or disablement is occasioned by Licensee's breach of its
obligations hereunder, the CBOT shall use good faith efforts to (x) return or
reinstate the Licensed Products or the relevant part or parts thereof (as the
case may be), or (y) as soon as reasonably practicable provide Licensee with
replacement products that will function in all material respects with the
repossessed or disabled Licensed Products (which will thereafter be "Licensed
Products" hereunder).

17.  Assignment and Sublicensing

     Except as expressly provided herein, Licensee shall not assign (by
operation of law or otherwise), sublicense, transfer, charge or part with the
possession of the benefits and obligations of, this Agreement (including, but
not limited to, the license granted under Section 2) without the prior written
consent of the CBOT. The CBOT may assign its rights and obligations hereunder
without Licensee's prior consent.

18.  Subcontractors

     The CBOT shall be entitled to appoint such subcontractors as it shall deem
fit to carry out the whole or any part of its obligations hereunder.

19.  Third Party Beneficiary

     LIFFE shall be a third party beneficiary of this Agreement, thereby
entitled to receive the rights of the CBOT (excluding those set forth in
Sections 7 and 9), and enforce the provisions of this Agreement against
Licensee, or any other Person, to the same extent as if LIFFE had been a
signatory to this Agreement, in the courts and under the laws of the State of
Illinois, without giving effect to the provisions, policies or principles of any
state law relating to choice or conflict of laws. Notwithstanding the foregoing,
nothing in this Agreement will impose directly upon LIFFE any of the obligations
of the CBOT set forth herein.

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       8

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

20.  Force Majeure

     Except for the payment of any amounts due hereunder, if the performance of
this Agreement by either Party is prevented, hindered, delayed or otherwise made
impracticable by reason of any Force Majeure Event, that Party shall be excused
from such performance to the extent that it is prevented, hindered or delayed by
such cause.

21.  Entire Agreement

     This Agreement constitutes the entire understanding between the Parties
with respect to the subject matter hereof and supersedes all prior
representations, agreements, negotiations and discussions between the Parties.

22.  Amendments

     Except as expressly provided for herein, this Agreement may be amended only
by an instrument in writing signed on behalf of each of the Parties and in
compliance with law.

23.  Waiver

     The failure of a Party to exercise or enforce any right conferred upon it
by this Agreement shall not be deemed to be a waiver of any such right or
operate so as to bar the exercise or enforcement thereof at any time or times
hereafter.

24.  Notices

     Except as otherwise expressly provided herein, all notices, certifications,
requests, demands, payments and other communications hereunder: (a) shall be in
writing; (b) may be delivered by certified or registered mail, postage prepaid;
by hand; by facsimile; or by any internationally recognized private courier; (c)
shall be effective (i) if mailed, on the date three (3) days after the date of
mailing or (ii) if hand delivered, faxed, or delivered by private courier, on
the date of delivery; and (d) shall be addressed as follows:

                           If to Licensee:

                           -----------------------------------------------------
                           [address]

                           Attention:
                                      ------------------------------------------

                           If to the CBOT:

                           Board of Trade of the City of Chicago, Inc.
                           141 West Jackson Boulevard
                           Suite 600-A
                           Chicago, Illinois  60604
                           [Attention:                              ]
                                       -----------------------------
or to such other address or addresses as may hereafter be specified by notice
given by one Party to the other.

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       9

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

25.  Remedies Not Exclusive

     No remedy conferred by any provision of this Agreement is intended to be
exclusive of any other remedy (including, but not limited to, any remedy or
rights under the Rules), except as expressly provided in this Agreement, and
each and every remedy shall be cumulative and shall be in addition to every
other remedy given hereunder or now or hereafter existing in law or in equity or
by statute or otherwise.

26.  Binding Provisions

     This Agreement is binding upon, and shall inure to the benefit of, the
Parties and their respective administrators, legal representatives, successors,
and permitted assigns.

27.  Separability of Provisions

     Each provision of this Agreement shall be considered separable; and if, for
any reason, any provision of this Agreement is determined by a court of
competent jurisdiction to be invalid, unlawful, or unenforceable, such
determination shall not affect the enforceability of the remainder of this
Agreement or the validity, lawfulness, or enforceability of such provision in
any other jurisdiction.

28.  Interpretations

     References to sections and exhibits are to sections of and exhibits to this
Agreement. The headings are inserted for convenience of reference only and shall
not affect the construction of this Agreement. The masculine gender shall
include the feminine and the singular shall include the plural, and vice versa.

29.  Further Assurances

     The Parties shall execute all such further documents and do all such
further acts as may be necessary to carry the provisions of this Agreement into
full force and effect.

30.  Governing Law

     The validity and effectiveness of this Agreement shall be governed by and
construed and enforced in accordance with the internal laws of the State of
Illinois, without giving effect to the provisions, policies or principles of any
state law relating to choice or conflict of laws.

31.  Counterparts

     This Agreement may be executed in any number of counterparts, and by the
different Parties on separate counterparts, each of which when so executed and
delivered shall be an original, but all of which together shall constitute but
one and the same instrument. A complete set of counterparts shall be lodged with
each Party.

                  [Remainder of page intentionally left blank.
                            Signature page follows.]

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       10

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

     IN WITNESS WHEREOF, the Parties have executed this Interface Sublicense
Agreement as of the Effective Date.

                                     LICENSEE

                                     a(n) __________ [Form of Entity]

                                     By:
                                        ----------------------------------------
                                     Name:
                                          --------------------------------------
                                     Its:
                                         ---------------------------------------

                                    BOARD OF TRADE OF THE CITY OF CHICAGO, INC.,
                                    a Delaware corporation

                                     By:
                                        ----------------------------------------
                                     Name:
                                          --------------------------------------
                                     Its:
                                         ---------------------------------------

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

                                    EXHIBIT A

1.   Premises

2.   Interface Software

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

                                   SCHEDULE F

                                 SECURITY POLICY
                                 ---------------

1.   [**]

2.   [**]

3.   [**]

        3.1   [**]

        3.2   [**]

        3.3   [**]

4.   [**]

        4.1   [**]

        4.2   [**]

5.   [**]

        5.1   [**]

        5.2   [**]

        5.3   [**]

        5.4   [**]

        5.5   [**]

        5.6   [**]

        5.7   [**]

6.   [**]

        6.1   [**]

        6.2   [**]

        6.3   [**]

7.   [**]

        7.1   [**]

        7.2   [**]

8.   [**]

        8.1   [**]

9.   [**]

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

        9.1   [**]

        9.2   [**]

        9.3   [**]

        9.4   [**]

10.  [**]

     10.1.    [**]

     10.2.    [**]

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                        2

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

                                   SCHEDULE G
                                   ----------

                              THIRD PARTY SOFTWARE
                              --------------------

1. [**]

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

[**]

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                        2

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

[**]

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                        3

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

2. [**]

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

3. [**]

4. [**]

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

5. [**]

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       6

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

6. [**]

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

7. [**]

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       8

<PAGE>

8. [**]

9. [**]

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       9

<PAGE>

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       10

<PAGE>

10. [**]

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       11

<PAGE>

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       12

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

                                   SCHEDULE H

                           PREFERRED ESCROW AGREEMENT
                           --------------------------

                      Account Number ______________________

     This Preferred Escrow Agreement (this "Agreement") dated as of __________
___, 2003, is among Data Securities International, Inc. ("DSI"), LIFFE
Administration and Management, a company incorporated in England and Wales
("Depositor"), and Board of Trade of the City of Chicago, Inc., a Delaware
corporation ("Preferred Beneficiary"), who collectively may be referred to in
this Agreement as "the parties" and who are more fully identified in Exhibit A.

                                    RECITALS

     A. Depositor and Preferred Beneficiary have entered into that certain
Software License Agreement dated as of January 10, 2003, regarding certain
proprietary technology of Depositor (the "License Agreement").

     B. Depositor desires to avoid disclosure of its proprietary technology
except under certain limited circumstances.

     C. The proprietary technology of Depositor is used by Preferred Beneficiary
in the conduct of its business and, therefore, Preferred Beneficiary needs
access to the proprietary technology under certain limited circumstances.

     D. Depositor and Preferred Beneficiary desire to establish an escrow with
DSI to provide for the retention, administration and controlled access of the
proprietary technology materials of Depositor.

     E. The parties desire this Agreement to be supplementary to the License
Agreement pursuant to 11 United States Bankruptcy Code, Section 365(n).

                                   AGREEMENT

1.   Deposits

     1.1 Obligation to Make Deposit. Within six (6) months of the signing of
this Agreement by the parties, Depositor shall deliver to DSI the proprietary
information and other materials required to be deposited by the License
Agreement (the "Deposit Materials"), including, but not limited to, the source
code and relevant documentation relating to the then current versions of the
software components of the Licensed Technology (as such term is defined in the
License Agreement).

     1.2 Identification of Tangible Media. Prior to the delivery of the Deposit
Materials to DSI, Depositor shall conspicuously label for identification each
document, magnetic tape, disk, or other tangible media upon which the Deposit
Materials are written or stored. Additionally, Depositor shall complete
Exhibit B to this Agreement by listing each such tangible media by the item
label description, the type of media and the quantity. Exhibit B shall be signed
by Depositor and delivered to DSI with the Deposit Materials. Unless and until
Depositor makes the initial deposit with DSI, DSI shall have no obligation with
respect to this Agreement, except the obligation to notify the parties regarding
the status of the deposit account as required in Section 2.2 below.

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

     1.3 Deposit Inspection. When DSI receives the Deposit Materials and
Exhibit B, DSI will conduct a deposit inspection by visually matching the
labeling of the tangible media containing the Deposit Materials to the item
descriptions and quantity listed on Exhibit B.

     1.4 Acceptance of Deposit. At completion of the deposit inspection, if DSI
determines that the labeling of the tangible media matches the item descriptions
and quantity on Exhibit B, DSI will date and sign Exhibit B and mail a copy
thereof to Depositor and Preferred Beneficiary. If DSI determines that the
labeling does not match the item descriptions or quantity on Exhibit B, DSI will
(a) note the discrepancies in writing on Exhibit B; (b) date and sign Exhibit B
with the exceptions noted; and (c) provide a copy of Exhibit B to Depositor and
Preferred Beneficiary. DSI's acceptance of the deposit occurs upon the signing
of Exhibit B by DSI. Delivery of the signed Exhibit B to Preferred Beneficiary
is Preferred Beneficiary's notice that the Deposit Materials have been received
and accepted by DSI.

     1.5  Depositor's Representations. Depositor represents as follows:

     (a)  With respect to all of the Deposit Materials, Depositor has the
          requisite corporate power and authority to grant to DSI and Preferred
          Beneficiary the rights as provided in this Agreement;

     (b)  The Deposit Materials as of the date hereof are not subject to any
          lien or other encumbrance; and

     (c)  The Deposit Materials are readable and useable in their current form
          or, if the Deposit Materials are encrypted, the decryption tools and
          decryption keys have also been deposited.

     1.6 Verification. Preferred Beneficiary shall have the right, at Preferred
Beneficiary's expense, to cause a verification of any Deposit Materials. A
verification determines, in different levels of detail, the accuracy,
completeness, sufficiency and quality of the Deposit Materials. If a
verification is elected after the Deposit Materials have been delivered to DSI,
then only DSI, or at DSI's election an independent person or company selected
and supervised by DSI, may perform the verification, provided that such
verification does not disclose Depositor's source code or intellectual property
rights.

     1.7 Deposit Updates. Unless otherwise provided by the License Agreement,
Depositor shall update the Deposit Materials quarterly. Such updates will be
added to the existing deposit. All deposit updates shall be listed on a new
Exhibit B and the new Exhibit B shall be signed by Depositor. The processing of
all deposit updates shall be in accordance with Sections 1.2 through 1.6 above.
Each Exhibit B will be held and maintained separately within the escrow account.
An independent record will be created which will document the activity for each
Exhibit B. All references in this Agreement to the Deposit Materials shall
include the initial Deposit Materials and any updates. For the avoidance of
doubt, Depositor shall not have an obligation to update the Deposit Materials in
the event that the Deposit Materials have not been modified or enhanced since
the most recent prior deposit update.

     1.8 Removal of Deposit Materials. The Deposit Materials may be removed
and/or exchanged only on written instructions signed by Depositor, or as
otherwise provided in this Agreement. DSI shall notify Preferred Beneficiary
upon the removal of any Deposit Materials.

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                        2

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

2.   Confidentiality and Record Keeping

     2.1 Confidentiality. DSI shall maintain the Deposit Materials in a secure,
environmentally safe, locked facility which is accessible only to authorized
representatives of DSI. DSI shall have the obligation to reasonably protect the
confidentiality of the Deposit Materials. Except as provided in this Agreement,
DSI shall not disclose, transfer, make available, or use the Deposit Materials.
DSI shall not disclose the content of this Agreement to any third party. If DSI
receives a subpoena or other order of a court or other judicial tribunal
pertaining to the disclosure or release of the Deposit Materials, DSI will
immediately notify the parties to this Agreement. It shall be the responsibility
of Depositor and/or Preferred Beneficiary to challenge any such order; provided,
however, that DSI does not waive its rights to present its position with respect
to any such order. DSI will not be required to disobey any court or other
judicial tribunal order. (See Section 7.4 below for notices of requested
orders.)

     2.2 Status Reports. DSI will issue to Depositor and Preferred Beneficiary a
report profiling the account history at least semi-annually. DSI may provide
copies of the account history report upon the request of Depositor or Preferred
Beneficiary.

     2.3 Audit Rights. During the term of this Agreement, Depositor and
Preferred Beneficiary shall each have the right to inspect the written records
of DSI pertaining to this Agreement. Any inspection shall be held during normal
business hours and following three (3) days prior notice.

3.   Grant of Rights to DSI

     3.1 Title to Media. Depositor hereby transfers to DSI the title to the
media upon which any Deposit Materials are written or stored. However, this
transfer does not include the ownership of any Deposit Materials contained on
the media, including, but not limited to, United States and foreign copyrights,
copyright registrations, copyright registration applications, patents and patent
applications.

     3.2 Right to Make Copies. DSI shall have the right to make copies of the
Deposit Materials as reasonably necessary to fulfill its obligations under this
Agreement. DSI shall include all copyright, nondisclosure, and other proprietary
notices and titles contained on the Deposit Materials on any copies made by DSI.
With all Deposit Materials submitted to DSI, Depositor shall provide any and all
instructions as may be necessary to duplicate the Deposit Materials, including,
but not limited to, a description of the hardware and/or software needed.

     3.3 Right to Transfer Upon Release. During the term of this Agreement,
Depositor hereby grants to DSI the right to transfer a copy of the Deposit
Materials to Preferred Beneficiary upon any release of the Deposit Materials for
use by Preferred Beneficiary in accordance with Section 4. Except upon such a
release or as otherwise provided in this Agreement, DSI shall not transfer the
Deposit Materials.

4.   Release of Deposit

     4.1 Release Conditions. As used in this Agreement, "Release Conditions"
shall mean the existence of any one or more of the following circumstances:
Depositor (i) becomes insolvent, (ii) files for voluntary protection under the
bankruptcy laws of the United States or England and Wales, or (iii) becomes
subject to any involuntary bankruptcy or insolvency proceeding under laws of the
United States

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                        3

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

or England and Wales (which proceeding is not dismissed by a court of competent
jurisdiction within sixty (60) Business Days (as defined in the License
Agreement)) (an "Involuntary Proceeding").

     4.2 Filing For Release. If Preferred Beneficiary believes in good faith
that a Release Condition has occurred, Preferred Beneficiary may provide to DSI
written notice of the occurrence of the Release Condition and a request for the
release of the Deposit Materials. Upon receipt of such notice, DSI shall
promptly notify Depositor and provide a copy of the request to Depositor, by
certified mail, return receipt requested, or by commercial express mail.

     4.3 Contrary Instructions. From the date DSI mails the notice requesting
release of the Deposit Materials, Depositor shall have thirty (30) days to
deliver to DSI Contrary Instructions. "Contrary Instructions" shall mean the
written representation by Depositor that a Release Condition has not occurred or
has been cured. Upon receipt of Contrary Instructions, DSI shall notify
Preferred Beneficiary and send a copy of the Contrary Instructions to Preferred
Beneficiary by certified mail, return receipt requested, or by commercial
express mail. Additionally, DSI shall notify both Depositor and Preferred
Beneficiary that there is a dispute to be resolved pursuant to Section 7.3.
Subject to Section 5.3, DSI will continue to store the Deposit Materials without
release pending (a) joint instructions from Depositor and Preferred Beneficiary;
(b) resolution pursuant to Section 7.3; or (c) order of a court.

     4.4 Release of Deposit. If DSI does not receive Contrary Instructions from
the Depositor, DSI is authorized to release the Deposit Materials to the
Preferred Beneficiary at such location in the United States as is specified by
the Preferred Beneficiary. However, DSI is entitled to receive any fees then due
DSI pursuant to the terms of this Agreement before release of the Deposit
Materials. This Agreement will terminate upon the release of the Deposit
Materials held by DSI.

     4.5 Right to Use Following Release. Unless otherwise provided in the
License Agreement, upon release of the Deposit Materials in accordance with this
Section 4, Preferred Beneficiary shall have the right to use the Deposit
Materials for (i) a period not to exceed [**] months (the "Release Period"), and
(ii) the sole purpose of continuing Preferred Beneficiary's use of the Licensed
Technology as permitted by the License Agreement, provided that Preferred
Beneficiary shall have the right to modify the source code of Deposit Materials
comprising software only to the extent necessary to create Bug Fixes (as defined
in the License Agreement). The parties agree that (a) Depositor shall own any
and all modifications to, and derivative works based on, such Deposit Materials,
including any Bug Fixes created by Preferred Beneficiary ("Escrow Bug Fixes"),
(b) Preferred Beneficiary shall have a right to use the same during the term of
the License Agreement, and (c) neither Depositor nor Preferred Beneficiary may
charge the other party any fees or royalties relating to any such Escrow Bug
Fixes or the use thereof. Preferred Beneficiary shall be obligated to maintain
the confidentiality of the released Deposit Materials as provided in the License
Agreement.

     4.6 Release Upon an Involuntary Proceeding. In the event the Deposit
Materials are released due to an Involuntary Proceeding pursuant to Section 4.1
above, if such Involuntary Proceeding is dismissed during the Release Period,
Preferred Beneficiary must, unless otherwise agreed by Depositor and Preferred
Beneficiary, (a) return to Depositor all Deposit Materials and any Escrow Bug
Fixes, (b) provide Depositor with any modified source code (including source
code pertaining to any Escrow Bug Fixes) and a detailed description of all
modifications, or (c) destroy any and all copies of Deposit Materials in
Preferred Beneficiary's possession and/or control via a method which renders all
such copies permanently unrecoverable and certify any such copies as destroyed
via such a method.

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                        4

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

5.   Term and Termination

     5.1 Term of Agreement. The initial term of this Agreement is for a period
of one year. Thereafter, this Agreement shall automatically renew from
year-to-year unless (a) Depositor and Preferred Beneficiary jointly instruct DSI
in writing that the Agreement is terminated; or (b) the Agreement is terminated
by DSI for nonpayment in accordance with Section 5.2. If the Deposit Materials
are subject to another escrow agreement with DSI, DSI reserves the right, after
the initial one (1) year term, to adjust the anniversary date of this Agreement
to match the then prevailing anniversary date of such other escrow arrangement.

     5.2 Termination for Nonpayment. In the event of the nonpayment of fees owed
to DSI, DSI shall provide written notice of delinquency to all parties to this
Agreement. Any party to this Agreement shall have the right to make the payment
to DSI to cure the default. If the past due payment is not received in full by
DSI within one (1) month of the date of such notice, then DSI shall have the
right to terminate this Agreement at any time thereafter by sending written
notice of termination to all parties. DSI shall have no obligation to take any
action under this Agreement so long as any payment due to DSI remains unpaid.

     5.3 Disposition of Deposit Materials Upon Termination. Upon termination of
this Agreement, DSI shall destroy, return, or otherwise deliver the Deposit
Materials in accordance with signed, written instructions delivered by Depositor
to DSI. If there are no instructions, DSI may, at its sole discretion, destroy
the Deposit Materials or return them to Depositor. DSI shall have no obligation
to return or destroy the Deposit Materials if the Deposit Materials are subject
to another escrow agreement with DSI.

     5.4 Survival of Terms Following Termination. Upon termination of this
Agreement, the Sections 2.1, 5.3, 5.4, 6.1, 7 and 8 shall survive.

6.   Fees

     6.1 Fee Schedule. DSI is entitled to be paid its standard fees and expenses
applicable to the services provided. Preferred Beneficiary shall be responsible
for payment of all fees and expenses owed to DSI pursuant to this Agreement. DSI
shall notify Preferred Beneficiary at least sixty (60) days prior to any
increase in fees. For any service not listed on DSI's standard fee schedule, DSI
will provide a quote prior to rendering the service, if requested.

     6.2 Payment Terms. DSI shall not be required to perform any service unless
all amounts then due are paid in full. All fees are due thirty (30) days after
receipt of invoice. If invoiced fees are not paid, DSI may terminate this
Agreement in accordance with Section 5.2. Late fees on past due amounts shall
accrue interest at the rate of one and one-half (1.5%) percent per month
(eighteen percent (18%) per annum) from the date of the invoice.

7.   Liability and Disputes

     7.1 Right to Rely on Instructions. DSI may act in reliance upon any
instruction, instrument, or signature reasonably believed by DSI to be genuine.
DSI may assume that any employee of a party to this Agreement who gives any
written notice, request, or instruction has the authority to do so. DSI shall
not be responsible for failure to act as a result of causes beyond the
reasonable control of DSI.

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                        5

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

     7.2 Indemnification. DSI shall be responsible to perform its obligations
under this Agreement and to act in a reasonable and prudent manner with regard
to this escrow arrangement. Provided DSI has acted in such reasonable and
prudent manner, Depositor and Preferred Beneficiary each agree to indemnify,
defend and hold harmless DSI from any claims and all damages, arbitration fees
and expenses, costs, attorney's fees and other liabilities resulting therefrom
(collectively, the "Liabilities") incurred by DSI relating in any way to this
escrow arrangement, except for any Liabilities related to the adjudged gross
negligence or willful misconduct of DSI. Depositor shall have sole control over
the defense of any such claim and neither Depositor of Preferred Beneficiary
shall be liable hereunder for any settlement or compromise negotiated by DSI
unless such party agrees in writing to be so bound.

     7.3 Dispute Resolution. Any dispute relating to or arising from this
Agreement shall be resolved by arbitration under the Commercial Rules of the
American Arbitration Association. Three arbitrators shall be selected. Depositor
and Preferred Beneficiary shall each select one arbitrator and the two chosen
arbitrators shall select the third arbitrator, or failing agreement on the
selection of the third arbitrator, the American Arbitration Association shall
select the third arbitrator. However, if DSI is a party to the arbitration, DSI
shall select the third arbitrator. Unless otherwise agreed by Depositor and
Preferred Beneficiary, arbitration will take place in Chicago, Illinois. Any
court having jurisdiction over the matter may enter judgment on the award of the
arbitrator(s). Service of a petition to confirm the arbitration award may be
made by First Class mail or by commercial express mail, to the attorney for the
party or, if unrepresented, to the party at the last known business address.

     7.4 Notice of Requested Order. If any party intends to obtain an order from
the arbitrator or any court of competent jurisdiction which may direct DSI to
take, or refrain from taking any action, that party shall:

     (a)  Give DSI at least two US business days' prior notice of the hearing;

     (b)  Include in any such order that, as a precondition to DSI's obligation,
          DSI be paid in full for any past due fees and be paid for the
          reasonable value of the services to be rendered pursuant to such
          order; and

     (c)  Ensure that DSI not be required to deliver the original (as opposed to
          a copy) of the Deposit Materials if DSI may need to retain the
          original in its possession to fulfill any of its other duties.

8.   General Provisions

     8.1 Entire Agreement. This Agreement, which includes the exhibits described
herein, embodies the entire understanding among the parties with respect to its
subject matter and supersedes all previous communications, representations or
understandings, either oral or written. DSI is not a party to the license
agreement between Depositor and Preferred Beneficiary and has no knowledge of
any of the terms or provisions of any such license agreement. DSI's only
obligations to Depositor or Preferred Beneficiary are as set forth in this
Agreement. No amendment or modification of this Agreement shall be valid or
binding unless signed by all the parties hereto, except that Exhibit A need not
be signed and Exhibit B need not be signed by Preferred Beneficiary.

     8.2 Notices. Any notices hereunder shall be in writing and shall be deemed
to be sufficiently given to the addressee and any delivery hereunder deemed
made: (i) ten (10) business days after deposit

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                        6

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

with the United States Postal Service, via registered air-mail, return receipt
requested, postage pre-paid, (ii) five (5) business days after deposit with a
reputable commercial express mail courier or (iii) one (1) business day after
facsimile transmission (provided the sender receives an automated confirmation
of transmission), in each case sent to the parties at the addresses specified in
Exhibit A. The parties may change the addresses or fax numbers for notice
hereunder by delivery of notice in accordance with the provisions of this
section.

     8.3 Governing Law. This Agreement is to be governed and construed in
accordance with the laws of the State of Illinois, without regard to its
conflict of law provisions.

     8.4 Severability. In the event any provision of this Agreement is found to
be invalid, voidable or unenforceable, the parties agree that unless it
materially affects the entire intent and purpose of this Agreement, such
invalidity, voidability or unenforceability shall affect neither the validity of
this Agreement nor the remaining provisions herein, and the provision in
question shall be deemed to be replaced with a valid and enforceable provision
most closely reflecting the intent and purpose of the original provision.

     8.5 Successors. This Agreement shall be binding upon and shall inure to the
benefit of the successors and assigns of the parties. However, DSI shall have no
obligation in performing this Agreement to recognize any successor or assign of
Depositor or Preferred Beneficiary unless DSI receives clear, authoritative and
conclusive written evidence of the change of parties.

     8.6 Regulations. Depositor and Preferred Beneficiary are responsible for
all laws, rules and regulations applicable to performance of their respective
obligations of Depositor and Preferred Beneficiary hereunder, including but not
limited to customs laws, import, export, and re-export laws and government
regulations of any country to which the Deposit Materials may be delivered in
accordance with the provisions of this Agreement.

     8.7 Counterparts. This Agreement may be executed in any number of
counterparts, and by the different Parties on separate counterparts, each of
which when so executed and delivered shall be an original, but all of which
together shall constitute but one and the same instrument. A complete set of
counterparts shall be lodged with each Party.

                  [Remainder of page intentionally left blank.
                            Signature page follows.]

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       7

<PAGE>

                      CONFIDENTIAL TREATMENT REQUESTED BY
                              CBOT HOLDINGS, INC.

     IN WITNESS WHEREOF, the parties have executed this Preferred Escrow
Agreement as of the date first above written.

                                     LIFFE ADMINISTRATION AND MANAGEMENT

                                     By:
                                          --------------------------------
                                     Name:
                                          --------------------------------
                                     Title:
                                          --------------------------------
                                     Date:
                                         --------------------------------

                                     BOARD OF TRADE OF THE CITY OF CHICAGO, INC.

                                     By:
                                       -----------------------------------------
                                     Name:
                                         ---------------------------------------
                                     Title:
                                          --------------------------------------
                                     Date:
                                         ---------------------------------------

                                     DATA SECURITIES INTERNATIONAL, INC.

                                     By:
                                       -----------------------------------------
                                     Name:
                                         ---------------------------------------
                                     Title:
                                          --------------------------------------
                                     Date:
                                          --------------------------------------

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       8

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

                                                                       EXHIBIT A

                               DESIGNATED CONTACT

                      Account Number ______________________

<TABLE>
<S>                                              <C>
Notices, deposit material returns and
communications to Depositor                      Invoices to Depositor should be
should be addressed to:                          addressed to:

Company Name:________________________________    _____________________________________________

Address:_____________________________________    _____________________________________________

        _____________________________________    _____________________________________________

        _____________________________________    _____________________________________________

Designated Contact:__________________________    Contact:_____________________________________

Telephone:___________________________________    _____________________________________________

Facsimile:___________________________________    P.O.#, if required:__________________________

Notices and communications to                    Invoices to Preferred Beneficiary
Preferred Beneficiary should be addressed to:    should be addressed to:

Company Name:________________________________    _____________________________________________

Address:_____________________________________    _____________________________________________

        _____________________________________    _____________________________________________

        _____________________________________    _____________________________________________

Designated Contact:__________________________    Contact:_____________________________________

Telephone:___________________________________    _____________________________________________

Facsimile:___________________________________    P.O.#, if required:__________________________

Requests from Depositor or Preferred Beneficiary to change the designated contact should be
given in writing by the designated contact or an authorized employee of Depositor or Preferred
Beneficiary.

Contracts, Deposit Materials and notices to      Invoice inquiries and fee remittances
DSI should be addressed to:                      to DSI should be addressed to:

DSI                                              DSI
Contract Administration                          Accounts Receivable
Suite 200                                        Suite 1450
9555 Chesapeake Drive                            425 California Street
San Diego, CA 92123                              San Francisco, CA 94104

Telephone: (619) 694-1900                        (415) 398-7900
Facsimile: (619) 694-1919                        (415) 398-7914
</TABLE>

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       A-1

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

Date:_________________________________

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       A-2

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

                                                                       EXHIBIT B

                        DESCRIPTION OF DEPOSIT MATERIALS

<TABLE>
<S>          <C>                         <C>
Depositor Company Name _______________________________________________________________________
Account Number _______________________________________________________________________________
Product Name ______________________________________________Version ___________________________
(Product Name will appear on Account History report)

DEPOSIT MATERIAL DESCRIPTION:
Quantity     Media Type & Size                  Label Description of Each Separate Item
                                         (Please use other side if additional space is needed)
_______      Disk 3.5" or ____
_______      DAT tape ____mm
_______      CD-ROM
_______      Data cartridge tape ____
_______      TK 70 or ____ tape
_______      Magnetic tape ____
_______      Documentation
_______      Other __________________

PRODUCT DESCRIPTION:
Operating System _____________________________________________________________________________
Hardware Platform_____________________________________________________________________________

DEPOSIT COPYING INFORMATION:
Is the media encrypted?  Yes / No   If yes, please include any passwords and the decryption
tools.
Encryption tool name_______________________________________ Version __________________________

Hardware required ____________________________________________________________________________
Software required ____________________________________________________________________________

I certify for Depositor that the above described   DSI has inspected and accepted the above
Deposit Materials have been transmitted to DSI:    materials (any exceptions are noted above):

Signature _________________________________        Signature _________________________________
Print Name ________________________________        Print Name ________________________________
Date ______________________________________        Date Accepted _____________________________
                                                   Exhibit B# ________________________________

    Send materials to: DSI, 9555 Chesapeake Dr. #200, San Diego, CA 92123 (619)694-1900
</TABLE>

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

                                       B-1

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

                  CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]

<PAGE>

                       CONFIDENTIAL TREATMENT REQUESTED BY
                               CBOT HOLDINGS, INC.

                                   SCHEDULE I

                                      FEES
                                      ----

Part 1 - Initial Term License Fee
         ------------------------

     The License Fee payable under this Agreement for the duration of the
     Initial Term is [**], which shall be paid as follows:

     (a)  The CBOT shall pay to LIFFE [**];

     (b)  LIFFE shall invoice the CBOT for [**];
          and

     (c)  LIFFE shall invoice the CBOT for [**].

Part 2 - Renewal Term License Fee
         ------------------------

2.1  The License Fee payable in respect of the Renewal Term immediately
     following the Initial Term (the "First Renewal Term") shall be calculated
     as follows: [**] per annum adjusted by the greater of (a) [**] per annum
     during the Initial Term or (b) the percentage change in the [**] as
     published by the [**] during the Initial Term, as measured by the change
     between the [**] number for the month before the month in which the Initial
     Term began and for the month before the month in which the first day of the
     First Renewal Term begins; provided that the License Fee shall not be
     adjusted by more than [**].

2.2  The License Fee payable in respect of the Renewal Term immediately
     following the First Renewal Term (the "Second Renewal Term") shall be
     calculated as follows: the annual License Fee payable for the First Renewal
     Term adjusted by the greater of (a) [**] percent [**] per annum during the
     First Renewal Term or (b) the percentage change in the [**] as published by
     the [**] during the Initial Term, as measured by the change between the
     [**] number for the month before the month in which the First Renewal Term
     began and for the month before the month in which the first day of the
     Second Renewal Term begins; provided that the License Fee shall not be
     adjusted by more than [**].

2.3  LIFFE shall be entitled to invoice the CBOT for the full amount of the
     License Fee for each Renewal Term [**].

                   CONFIDENTIAL INFORMATION REDACTED AND FILED
       SEPARATELY WITH THE COMMISSION. OMITTED PORTIONS INDICATED BY [**]<PAGE>

                                                                    Exhibit 10.1

                                                                  EXECUTION COPY

================================================================================

                                  A/B EXCHANGE
                          REGISTRATION RIGHTS AGREEMENT

                          Dated as of December 17, 2002
                                  by and among

                                 Roundy's, Inc.
                                    as Issuer

                   The Guarantors listed on Schedule A hereto

                                       and

                            Bear, Stearns & Co. Inc.,
                            CIBC World Markets Corp.
                              as Initial Purchasers

================================================================================

<PAGE>

     This Registration Rights Agreement (this "Agreement") is made and entered
into as of December 17,, 2002 by and among Roundy's, Inc., a Wisconsin
corporation (the "Company" and the "Issuer"), the Company's domestic
subsidiaries listed on Schedule A (the "Guarantors"), and Bear, Stearns & Co.
Inc. and CIBC World Markets Corp. (each an "Initial Purchaser" and,
collectively, the "Initial Purchasers"), each of whom has agreed to purchase the
Company's 8 7/8% Series A Senior Subordinated Notes due 2012 (the "Series A
Notes") pursuant to the Purchase Agreement (as defined below).

     This Agreement is made pursuant to the Purchase Agreement, dated December
12, 2002, (the "Purchase Agreement"), by and among the Company, the Guarantors
and the Initial Purchasers. In order to induce the Initial Purchasers to
purchase the Series A Notes, the Company has agreed to provide the registration
rights set forth in this Agreement. The execution and delivery of this Agreement
is a condition to the obligations of the Initial Purchasers set forth in Section
7 of the Purchase Agreement. Capitalized terms used herein and not otherwise
defined shall have the meaning assigned to them in the Indenture, dated June 6,
2002, between the Company, the Guarantors and BNY Midwest Trust Company, as
Trustee, relating to the Series A Notes and the Series B Notes (the
"Indenture").

     The parties hereby agree as follows:

SECTION 1. DEFINITIONS

     As used in this Agreement, the following capitalized terms shall have the
following meanings:

     Act: The Securities Act of 1933, as amended.

     Affiliate: As defined in Rule 144 of the Act.

     Broker-Dealer: Any broker or dealer registered under the Exchange Act.

     Certificated Securities: Definitive Notes, as defined in the Indenture.

     Closing Date: The date hereof.

     Commission: The Securities and Exchange Commission.

     Consummate: An Exchange Offer shall be deemed "Consummated" for purposes of
this Agreement upon the occurrence of (a) the filing and effectiveness under the
Act of the Exchange Offer Registration Statement relating to the Series B Notes
to be issued in the Exchange Offer, (b) the maintenance of such Exchange Offer
Registration Statement continuously effective and the keeping of the Exchange
Offer open for a period not less than the period required pursuant to Section
3(b) hereof and (c) the delivery by the Company to the Registrar under the
Indenture of Series B Notes in the same aggregate principal amount as the
aggregate principal amount of Series A Notes tendered by Holders thereof
pursuant to the Exchange Offer.

     Exchange Act: The Securities Exchange Act of 1934, as amended.

<PAGE>

     Exchange Consummation Deadline: As defined in Section 3(b) hereof.

     Exchange Effectiveness Deadline: As defined in Section 3(a) hereof.

     Exchange Filing Deadline: As defined in Sections 3(a) hereof.

     Exchange Offer: The exchange and issuance by the Company of a principal
amount of Series B Notes (which shall be registered pursuant to the Exchange
Offer Registration Statement) equal to the outstanding principal amount of
Series A Notes that are tendered by such Holders in connection with such
exchange and issuance.

     Exchange Offer Registration Statement: The Registration Statement relating
to the Exchange Offer, including the related Prospectus.

     Exempt Resales: The transactions in which the Initial Purchasers propose to
sell the Series A Notes to certain "qualified institutional buyers," as such
term is defined in Rule 144A under the Act, to certain "accredited investors,"
as such term is defined in Rule 501(a)(1), (2), (3) and (7) of Regulation D
under the Act and pursuant to Regulation S under the Act.

     Holders: As defined in Section 2 hereof.

     Person: Means any individual, corporation, partnership, joint venture,
association, joint-stock company, trust, unincorporated organization, limited
liability company or government or other entity.

     Prospectus: The prospectus included in a Registration Statement at the time
such Registration Statement is declared effective, as amended or supplemented by
any prospectus supplement and by all other amendments thereto, including
post-effective amendments, and all material incorporated by reference into such
Prospectus.

     Recommencement Date: As defined in Section 6(d) hereof.

     Registration Default: As defined in Section 5 hereof.

     Registration Statement: Any registration statement of the Company and the
Guarantors relating to (a) an offering of Series B Notes pursuant to an Exchange
Offer or (b) the registration for resale of Transfer Restricted Securities
pursuant to the Shelf Registration Statement, in each case, (i) that is filed
pursuant to the provisions of this Agreement and (ii) including the Prospectus
included therein, all amendments and supplements thereto (including
post-effective amendments) and all exhibits and material incorporated by
reference therein.

     Regulation S: Regulation S promulgated under the Act.

     Rule 144: Rule 144 promulgated under the Act.

     Series B Notes: The Company's 8 7/8% Series B Senior Subordinated Notes due
2012 to be issued pursuant to the Indenture: (i) in the Exchange Offer or (ii)
as contemplated by Section 4 hereof.

                                       2

<PAGE>

     Shelf Effectiveness Deadline: As defined in Section 4(a) hereof.

     Shelf Filing Deadline: As defined in Sections 4(a) hereof.

     Shelf Registration Statement: As defined in Section 4 hereof.

     Suspension Notice: As defined in Section 6(d) hereof.

     TIA: The Trust Indenture Act of 1939 (15 U.S.C. Section 77aaa-77bbbb) as in
effect on the date of the Indenture.

     Transfer Restricted Securities: Each (A) Series A Note, until the earliest
to occur of (i) the date on which such Series A Note has been exchanged by a
Person other than a Broker-Dealer for a Series B Note in the Exchange Offer;
(ii) following the exchange by a Broker-Dealer in the Exchange Offer of a Series
A Note for a Series B Note, the date on which such Exchange Note is sold to a
purchaser who receives from such Broker-Dealer on or prior to the date of such
sale a copy of the Prospectus; (iii) the date on which such Series A Note has
been effectively registered under the Act and disposed of in accordance with the
Shelf Registration Statement (and the purchasers thereof have been issued Series
B Notes) or (iv) the date on which such Series A Note is distributed to the
public pursuant to Rule 144 under the Act.

SECTION 2. HOLDERS

     A Person is deemed to be a holder of Transfer Restricted Securities (each,
a "Holder") whenever such Person owns Transfer Restricted Securities.

SECTION 3. REGISTERED EXCHANGE OFFER

     (a) Unless the Exchange Offer shall not be permitted by applicable federal
law or Commission policy (after the procedures set forth in Section 6(a)(i)
hereof have been complied with), the Company and the Guarantors shall (i) cause
the Exchange Offer Registration Statement to be filed with the Commission as
soon as practicable after the Closing Date, but in no event later than 90 days
after the Closing Date (such 90th day being the "Exchange Filing Deadline"),
(ii) use its reasonable best efforts to cause such Exchange Offer Registration
Statement to be declared effective by the Commission on or prior to 180 days
after the Closing Date (such 180th day being the "Exchange Effectiveness
Deadline"), (iii) in connection with the foregoing, (A) file all pre-effective
amendments to such Exchange Offer Registration Statement as may be necessary in
order to cause it to become effective, (B) file, if applicable, a post-effective
amendment to such Exchange Offer Registration Statement pursuant to Rule 430A
under the Act and (C) cause all necessary filings, if any, in connection with
the registration and qualification of the Series B Notes to be made under the
Blue Sky laws of such jurisdictions as are necessary to permit Consummation of
the Exchange Offer, and (iv) upon the effectiveness of such Exchange Offer
Registration Statement, commence and, within the time period set forth in
Section 3(b) hereof, Consummate the Exchange Offer. The Exchange Offer shall be
on the appropriate form permitting (i) registration of the Series B Notes to be
offered in exchange for the Series A Notes that are Transfer Restricted
Securities and (ii) resales of Series B Notes by Broker-Dealers that tendered
into the Exchange Offer Series A Notes that such Broker-Dealer acquired for its
own account as a result of market making activities or other trading activities

                                       3

<PAGE>

(other than Series A Notes acquired directly from the Company or any of its
Affiliates) as contemplated by Section 3(c) hereof.

     (b) The Company and the Guarantors shall use their respective reasonable
best efforts to cause the Exchange Offer Registration Statement to be effective
continuously, and shall keep the Exchange Offer open for a period of not less
than the minimum period required under applicable federal and state securities
laws to Consummate the Exchange Offer; provided, however, that in no event shall
such period be less than 20 Business Days. The Company and the Guarantors shall
cause the Exchange Offer to comply with all applicable federal and state
securities laws. No securities other than the Series B Notes shall be included
in the Exchange Offer Registration Statement. The Company and the Guarantors
shall use their respective reasonable best efforts to cause the Exchange Offer
to be Consummated within 30 days after the date on which the Exchange Offer
Registration Statement was declared effective by the Commission (such 30th day
being the "Exchange Consummation Deadline").

     (c) The Company shall include a "Plan of Distribution" section in the
Prospectus contained in the Exchange Offer Registration Statement and indicate
therein that any Broker-Dealer who holds Transfer Restricted Securities that
were acquired for the account of such Broker-Dealer as a result of market-making
activities or other trading activities (other than Series A Notes acquired
directly from the Company or any Affiliate of the Company), may exchange such
Transfer Restricted Securities pursuant to the Exchange Offer. Such "Plan of
Distribution" section shall also contain all other information with respect to
such sales by such Broker-Dealers that the Commission may require in order to
permit such sales pursuant thereto, but such "Plan of Distribution" shall not
name any such Broker-Dealer or disclose the amount of Transfer Restricted
Securities held by any such Broker-Dealer, except to the extent required by the
Commission as a result of a change in policy, rules or regulations after the
date of this Agreement. See the Shearman & Sterling no-action letter (available
July 2, 1993).

     Because such Broker-Dealer may be deemed to be an "underwriter" within the
meaning of the Act and must, therefore, deliver a prospectus meeting the
requirements of the Act in connection with its initial sale of any Series B
Notes received by such Broker-Dealer in the Exchange Offer, the Company and
Guarantors shall permit the use of the Prospectus contained in the Exchange
Offer Registration Statement by such Broker-Dealer to satisfy such prospectus
delivery requirement. To the extent necessary to ensure that the prospectus
contained in the Exchange Offer Registration Statement is available for sales of
Series B Notes by Broker-Dealers, the Company and the Guarantors agree to use
their respective best efforts to keep the Exchange Offer Registration Statement
continuously effective, supplemented, amended and current as required by and
subject to the provisions of Section 6(a) and Section 6(c) hereof and in
conformity with the requirements of this Agreement, the Act and the policies,
rules and regulations of the Commission as announced from time to time, for a
period of one year from the Exchange Consummation Deadline or such shorter
period as will terminate when all Transfer Restricted Securities covered by such
Registration Statement have been sold pursuant thereto. The Company and the
Guarantors shall provide sufficient copies of the latest version of such
Prospectus to such Broker-Dealers, promptly upon request at any time during such
period.

                                       4

<PAGE>

SECTION 4. SHELF REGISTRATION

     (a) Shelf Registration. If (i) the Company and the Guarantors are not (A)
required to file the Exchange Offer Registration Statement or (B) permitted to
Consummate the Exchange Offer because the Exchange Offer is not permitted by
applicable law or Commission policy (after the Company and the Guarantors have
complied with the procedures set forth in Section 6(a)(i) hereof) or (ii) if any
Holder of Transfer Restricted Securities shall notify the Company prior to the
20th Business Days following the Consummation of the Exchange Offer that (A)
such Holder was prohibited by law or Commission policy from participating in the
Exchange Offer or (B) such Holder may not resell the Series B Notes acquired by
it in the Exchange Offer to the public without delivering a prospectus and the
Prospectus contained in the Exchange Offer Registration Statement is not
appropriate or available for such resales by such Holder or (C) such Holder is a
Broker-Dealer and holds Series A Notes acquired directly from the Company or any
of its Affiliates, then the Company and the Guarantors shall:

     (x) use their reasonable best efforts to cause to be filed, on or prior to
90 days after the earlier of (i) the date on which the Company determines that
the Exchange Offer Registration Statement cannot be filed as a result of clause
(a)(i) of this Section 4 and (ii) the date on which the Company receives the
notice specified in clause (a)(ii) of this Section 4, (such 90th day after the
earlier date, the "Shelf Filing Deadline"), a shelf registration statement
pursuant to Rule 415 under the Act, which may be an amendment to the Exchange
Offer Registration Statement (the "Shelf Registration Statement"), relating to
all Transfer Restricted Securities, and

     (y) use their respective reasonable best efforts to cause such Shelf
Registration Statement to become effective on or prior to 180 days after the
Shelf Filing Deadline (such 180th day the "Shelf Effectiveness Deadline").

     If, after the Company has filed an Exchange Offer Registration Statement
that satisfies the requirements of Section 3(a) hereof, the Company is required
to file and make effective a Shelf Registration Statement solely because the
Exchange Offer is not permitted under applicable federal law (i.e., clause
(a)(i) of this Section 4), then the filing of the Exchange Offer Registration
Statement shall be deemed to satisfy the requirements of clause (x) of this
Section 4; provided that, in such event, the Company shall remain obligated to
meet the Shelf Effectiveness Deadline set forth in clause (y) of this Section 4.

     To the extent necessary to ensure that the Shelf Registration Statement is
available for sales of Transfer Restricted Securities by the Holders thereof
entitled to the benefit of this Section 4(a) and the other securities required
to be registered therein pursuant to Section 6(b)(ii) hereof, the Company and
the Guarantors shall use their respective best efforts to keep any Shelf
Registration Statement required by this Section 4(a) continuously effective,
supplemented, amended and current as required by and subject to the provisions
of Section 6(b) and Section (c) hereof and in conformity with the requirements
of this Agreement, the Act and the policies, rules and regulations of the
Commission as announced from time to time, for a period of at least two years
(as extended pursuant to Section 6(c)(i) hereof) following the Closing Date, or
such shorter period as will terminate when all Transfer Restricted Securities
covered by such Shelf Registration Statement have been sold pursuant thereto.

                                       5

<PAGE>

     (b) Provision by Holders of Certain Information in Connection with the
Shelf Registration Statement. No Holder of Transfer Restricted Securities may
include any of its Transfer Restricted Securities in any Shelf Registration
Statement pursuant to this Agreement unless and until such Holder furnishes to
the Company in writing, within 20 days after receipt of a request therefor, the
information specified in Item 507 or Item 508 of Regulation S-K, as applicable,
of the Act for use in connection with any Shelf Registration Statement or
Prospectus or preliminary Prospectus included therein. No Holder of Transfer
Restricted Securities shall be entitled to liquidated damages pursuant to
Section 5 hereof unless and until such Holder shall have provided all such
information. Each selling Holder agrees to promptly furnish additional
information required to be disclosed in order to make the information previously
furnished to the Company by such Holder not materially misleading.

SECTION 5. LIQUIDATED DAMAGES

     If (i) any Registration Statement required by this Agreement is not filed
with the Commission on or prior to the Exchange Filing Deadline or the Shelf
Filing Deadline, as applicable, (ii) any such Registration Statement has not
been declared effective by the Commission on or prior to the Exchange
Effectiveness Deadline or the Shelf Effectiveness Deadline, as applicable, (iii)
the Exchange Offer has not been Consummated on or prior to the Exchange
Consummation Deadline or (iv) any Registration Statement required by this
Agreement is filed and declared effective but shall thereafter cease to be
effective or fail to be usable for its intended purpose without being succeeded
immediately by a post-effective amendment to such Registration Statement that
cures such failure and that is itself declared effective immediately (each such
event referred to in clauses (i) through (iv) above, a "Registration Default"),
then the Company and the Guarantors hereby jointly and severally agree to pay to
each Holder of Transfer Restricted Securities affected thereby liquidated
damages in an amount equal to $.05 per week per $1,000 in principal amount of
Transfer Restricted Securities held by such Holder for each week or portion
thereof that the Registration Default continues for the first 90-day period
immediately following the occurrence of such Registration Default. The amount of
the liquidated damages shall increase by an additional $.05 per week per $1,000
in principal amount of Transfer Restricted Securities with respect to each
subsequent 90-day period until all Registration Defaults have been cured, up to
a maximum amount of liquidated damages of $.50 per week per $1,000 in principal
amount of Transfer Restricted Securities; provided that the Company and the
Guarantors shall in no event be required to pay liquidated damages for more than
one Registration Default at any given time. Notwithstanding anything to the
contrary set forth herein, (1) upon filing of the Exchange Offer Registration
Statement (and/or, if applicable, the Shelf Registration Statement), in the case
of (i) above, (2) upon the effectiveness of the Exchange Offer Registration
Statement (and/or, if applicable, the Shelf Registration Statement), in the case
of (ii) above, (3) upon Consummation of the Exchange Offer, in the case of (iii)
above, or (4) upon the filing of a post-effective amendment to the Registration
Statement or an additional Registration Statement that causes the Exchange Offer
Registration Statement (and/or, if applicable, the Shelf Registration Statement)
to again be declared effective or made usable in the case of (iv) above, the
liquidated damages payable with respect to the Transfer Restricted Securities as
a result of such clause (i), (ii), (iii) or (iv), as applicable, shall cease.

                                       6

<PAGE>

     All accrued liquidated damages shall be paid to the Holders entitled
thereto, in the manner provided for the payment of interest in the Indenture, on
each Interest Payment Date, as more fully set forth in the Indenture and the
Notes. Notwithstanding the fact that any securities for which liquidated damages
are due cease to be Transfer Restricted Securities, all obligations of the
Company and the Guarantors to pay liquidated damages with respect to securities
shall survive until such time as such obligations with respect to such
securities shall have been satisfied in full.

SECTION 6. REGISTRATION PROCEDURES

     (a) Exchange Offer Registration Statement. In connection with the Exchange
Offer, the Company and the Guarantors shall (x) comply with all applicable
provisions of Section 6(c) hereof, (y) use their respective best efforts to
effect such exchange and to permit the resale of Series B Notes by
Broker-Dealers that tendered in the Exchange Offer Series A Notes that such
Broker-Dealer acquired for its own account as a result of its market making
activities or other trading activities (other than Series A Notes acquired
directly from the Company or any of its Affiliates) being sold in accordance
with the intended method or methods of distribution thereof, and (z) comply with
all of the following provisions:

          (i) If, following the date hereof there has been announced a change in
     Commission policy with respect to exchange offers such as the Exchange
     Offer, that in the reasonable opinion of counsel to the Company raises a
     substantial question as to whether the Exchange Offer is permitted by
     applicable federal law, the Company and the Guarantors hereby agree to seek
     a no-action letter or other favorable decision from the Commission allowing
     the Company and the Guarantors to Consummate an Exchange Offer for such
     Transfer Restricted Securities. The Company and the Guarantors hereby agree
     to pursue the issuance of such a decision to the Commission staff level. In
     connection with the foregoing, the Company and the Guarantors hereby agree
     to take all such other actions as may be requested by the Commission or
     otherwise required in connection with the issuance of such decision,
     including without limitation (A) participating in telephonic conferences
     with the Commission, (B) delivering to the Commission staff an analysis
     prepared by counsel to the Company setting forth the legal bases, if any,
     upon which such counsel has concluded that such an Exchange Offer should be
     permitted and (C) diligently pursuing a resolution (which need not be
     favorable) by the Commission staff.

          (ii) As a condition to its participation in the Exchange Offer, each
     Holder of Transfer Restricted Securities (including, without limitation,
     any Holder who is a Broker Dealer) shall furnish, upon the request of the
     Company, prior to the Consummation of the Exchange Offer, a written
     representation to the Company and the Guarantors (which may be contained in
     the letter of transmittal contemplated by the Exchange Offer Registration
     Statement) to the effect that (A) it is not an Affiliate of the Company,
     (B) it is not engaged in, and does not intend to engage in, and has no
     arrangement or understanding with any person to participate in, a
     distribution of the Series B Notes to be issued in the Exchange Offer and
     (C) it is acquiring the Series B Notes in its ordinary course of business.
     As a condition to its participation in the Exchange Offer each Holder using
     the Exchange Offer to participate in a distribution of the Series B Notes
     shall acknowledge

                                       7

<PAGE>

     and agree that, if the resales are of Series B Notes obtained by such
     Holder in exchange for Series A Notes acquired directly from the Company or
     an Affiliate thereof, it (1) could not, under Commission policy as in
     effect on the date of this Agreement, rely on the position of the
     Commission enunciated in Exxon Capital Holdings Corporation (available May
     13, 1988) and Morgan Stanley and Co., Inc. (available June 5, 1991), as
     interpreted in the Commission's letter to Shearman & Sterling dated July 2,
     1993, and similar no-action letters (including, if applicable, any
     no-action letter obtained pursuant to clause (i) above), and (2) must
     comply with the registration and prospectus delivery requirements of the
     Act in connection with a secondary resale transaction and that such a
     secondary resale transaction must be covered by an effective registration
     statement containing the selling security holder information required by
     Item 507 or Item 508, as applicable, of Regulation S-K.

          (iii) Prior to effectiveness of the Exchange Offer Registration
     Statement, the Company and the Guarantors shall provide a supplemental
     letter to the Commission (A) stating that the Company and the Guarantors
     are registering the Exchange Offer in reliance on the position of the
     Commission enunciated in Exxon Capital Holdings Corporation (available May
     13, 1988), Morgan Stanley and Co., Inc. (available June 5, 1991) as
     interpreted in the Commission's letter to Shearman & Sterling dated July 2,
     1993, and, if applicable, any no-action letter obtained pursuant to clause
     (i) above, (B) including a representation that neither the Company nor any
     Guarantor has entered into any arrangement or understanding with any Person
     to distribute the Series B Notes to be received in the Exchange Offer and
     that, to the best of the Company's and each Guarantor's information and
     belief, each Holder participating in the Exchange Offer is acquiring the
     Series B Notes in its ordinary course of business and has no arrangement or
     understanding with any Person to participate in the distribution of the
     Series B Notes received in the Exchange Offer and (C) any other undertaking
     or representation required by the Commission as set forth in any no-action
     letter obtained pursuant to clause (i) above, if applicable.

     (b) Shelf Registration Statement. In connection with the Shelf Registration
Statement, the Company and the Guarantors shall (i) comply with all the
provisions of Section 6(c) hereof and use their respective reasonable best
efforts to effect such registration to permit the sale of the Transfer
Restricted Securities being sold in accordance with the intended method or
methods of distribution thereof (as indicated in the information furnished to
the Company pursuant to Section 4(b) hereof), and pursuant thereto the Company
and the Guarantors will prepare and file with the Commission a Registration
Statement relating to the registration on any appropriate form under the Act,
which form shall be available for the sale of the Transfer Restricted Securities
in accordance with the intended method or methods of distribution thereof within
the time periods and otherwise in accordance with the provisions hereof, and

          (ii) issue, upon the request of any Holder or purchaser of Series A
     Notes covered by any Shelf Registration Statement contemplated by this
     Agreement, Series B Notes having an aggregate principal amount equal to the
     aggregate principal amount of Series A Notes sold pursuant to the Shelf
     Registration Statement and surrendered to the Company for cancellation; the
     Company shall register Series B Notes on the Shelf Registration Statement
     for this purpose and issue the Series B Notes to the purchasers of

                                       8

<PAGE>

     securities subject to the Shelf Registration Statement in the names as such
     purchasers shall designate.

     (c) General Provisions. In connection with any Registration Statement and
any related Prospectus required by this Agreement, the Company and the
Guarantors shall:

          (i) use their respective reasonable best efforts to keep such
     Registration Statement continuously effective and provide all requisite
     financial statements for the period specified in Section 3 or Section 4 of
     this Agreement, as applicable. Upon the occurrence of any event that would
     cause any such Registration Statement or the Prospectus contained therein
     (A) to contain an untrue statement of material fact or omit to state any
     material fact necessary to make the statements therein not misleading or
     (B) not to be effective and usable for resale of Transfer Restricted
     Securities during the period required by this Agreement, the Company and
     the Guarantors shall file promptly an appropriate amendment to such
     Registration Statement curing such defect, and, if Commission review is
     required, use their respective reasonable best efforts to cause such
     amendment to be declared effective as soon as practicable.

          (ii) prepare and file with the Commission such amendments and
     post-effective amendments to the applicable Registration Statement as may
     be necessary to keep such Registration Statement effective for the
     applicable period set forth in Section 3 or Section 4 hereof, as the case
     may be; cause the Prospectus to be supplemented by any required Prospectus
     supplement, and as so supplemented to be filed pursuant to Rule 424 under
     the Act, and to comply fully with Rules 424, 430A and 462, as applicable,
     under the Act in a timely manner; and comply with the provisions of the Act
     with respect to the disposition of all securities covered by such
     Registration Statement during the applicable period in accordance with the
     intended method or methods of distribution by the sellers thereof set forth
     in such Registration Statement or supplement to the Prospectus;

          (iii) advise each Holder promptly and, if requested by such Holder,
     confirm such advice in writing, (A) when the Prospectus or any Prospectus
     supplement or post-effective amendment has been filed, and, with respect to
     any applicable Registration Statement or any post-effective amendment
     thereto, when the same has become effective, (B) of any request by the
     Commission for amendments to the Registration Statement or amendments or
     supplements to the Prospectus or for additional information relating
     thereto, (C) of the issuance by the Commission of any stop order suspending
     the effectiveness of the Registration Statement under the Act or of the
     suspension by any state securities commission of the qualification of the
     Transfer Restricted Securities for offering or sale in any jurisdiction, or
     the initiation of any proceeding for any of the preceding purposes and (D)
     of the existence of any fact or the happening of any event that makes any
     statement of a material fact made in the Registration Statement, the
     Prospectus, any amendment or supplement thereto or any document
     incorporated by reference therein untrue, or that requires the making of
     any additions to or changes in the Registration Statement in order to make
     the statements therein not misleading, or that requires the making of any
     additions to or changes in the Prospectus in order to make the statements
     therein, in the light of the circumstances under which they were made, not
     misleading. If at any time the Commission shall issue any stop order
     suspending the

                                       9

<PAGE>

     effectiveness of the Registration Statement, or any state securities
     commission or other regulatory authority shall issue an order suspending
     the qualification or exemption from qualification of the Transfer
     Restricted Securities under state securities or Blue Sky laws, the Company
     and the Guarantors shall use their respective best efforts to obtain the
     withdrawal or lifting of such order at the earliest possible time;

          (iv) subject to Section 6(c)(i) hereof, if any fact or event
     contemplated by Section 6(c)(iii)(D) above shall exist or have occurred,
     prepare a supplement or post-effective amendment to the Registration
     Statement or related Prospectus or any document incorporated therein by
     reference or file any other required document so that, as thereafter
     delivered to the purchasers of Transfer Restricted Securities, the
     Prospectus will not contain an untrue statement of a material fact or omit
     to state any material fact necessary to make the statements therein, in the
     light of the circumstances under which they were made, not misleading;

          (v) furnish to each Holder in connection with such exchange or sale,
     if any, before filing with the Commission, copies of any Registration
     Statement or any Prospectus included therein or any amendments or
     supplements to any such Registration Statement or Prospectus (including all
     documents incorporated by reference after the initial filing of such
     Registration Statement), which documents will be subject to the review and
     comment of such Holders in connection with such sale, if any, for a period
     of at least five Business Days, and the Company will not file any such
     Registration Statement or Prospectus or any amendment or supplement to any
     such Registration Statement or Prospectus (including all such documents
     incorporated by reference) to which such Holders shall reasonably object
     within five Business Days after the receipt thereof. A Holder shall be
     deemed to have reasonably objected to such filing if such Registration
     Statement, amendment, Prospectus or supplement, as applicable, as proposed
     to be filed, contains an untrue statement of a material fact or omit to
     state any material fact necessary to make the statements therein not
     misleading or fails to comply with the applicable requirements of the Act;

          (vi) promptly prior to the filing of any document that is to be
     incorporated by reference into a Registration Statement or Prospectus,
     provide copies of such document to each Holder in connection with such
     exchange or sale, if any, make the Company's and the Guarantors'
     representatives available for discussion of such document and other
     customary due diligence matters, and include such information in such
     document prior to the filing thereof as such Holders Persons may reasonably
     request;

          (vii) make available, at reasonable times, for inspection by each
     Holder and any attorney or accountant retained by such Holders, all
     financial and other records, pertinent corporate documents of the Company
     and the Guarantors and cause the Company's and the Guarantors' officers,
     directors and employees to supply all information reasonably requested by
     any such Holder, attorney or accountant in connection with such
     Registration Statement or any post-effective amendment thereto subsequent
     to the filing thereof and prior to its effectiveness;

                                       10

<PAGE>

          (viii) if requested by any Holders in connection with such exchange or
     sale, promptly include in any Registration Statement or Prospectus,
     pursuant to a supplement or post-effective amendment if necessary, such
     information as such Holders may reasonably request to have included
     therein, including, without limitation, information relating to the "Plan
     of Distribution" of the Transfer Restricted Securities; and make all
     required filings of such Prospectus supplement or post-effective amendment
     as soon as practicable after the Company is notified of the matters to be
     included in such Prospectus supplement or post-effective amendment;

          (ix) furnish to each Holder in connection with such exchange or sale,
     without charge, at least one copy of the Registration Statement, as first
     filed with the Commission, and of each amendment thereto, including all
     documents incorporated by reference therein and all exhibits (including
     exhibits incorporated therein by reference);

          (x) deliver to each Holder without charge, as many copies of the
     Prospectus (including each preliminary prospectus) and any amendment or
     supplement thereto as such Persons reasonably may request; the Company and
     the Guarantors hereby consent to the use (in accordance with law) of the
     Prospectus and any amendment or supplement thereto by each selling Holder
     in connection with the offering and the sale of the Transfer Restricted
     Securities covered by the Prospectus or any amendment or supplement
     thereto;

          (xi) upon the request of any Holder, enter into such agreements
     (including underwriting agreements) and make such representations and
     warranties and take all such other actions in connection therewith in order
     to expedite or facilitate the disposition of the Transfer Restricted
     Securities pursuant to any applicable Registration Statement contemplated
     by this Agreement as may be reasonably requested by any Holder in
     connection with any sale or resale pursuant to any applicable Registration
     Statement. In such connection, the Company and the Guarantors shall:

               (A) upon request of any Holder, furnish (or in the case of
          paragraphs (2) and (3) below, use its best efforts to cause to be
          furnished) to each Holder, upon Consummation of the Exchange Offer or
          upon the effectiveness of the Shelf Registration Statement, as the
          case may be:

                    (1) a certificate, dated such date, signed on behalf of the
               Company and each Guarantor by (x) the President or any Vice
               President and (y) a principal financial or accounting officer of
               the Company and such Guarantor, confirming, as of the date
               thereof, the matters set forth in Sections 8(a), 8(b), 8(c) and
               8(d) of the Purchase Agreement and such other similar matters as
               such Holders may reasonably request;

                    (2) opinion(s), dated the date of Consummation of the
               Exchange Offer or the date of effectiveness of the Shelf
               Registration Statement, as the case may be, of counsel for the
               Company and the Guarantors covering matters similar to those set
               forth in paragraph (f) of Section 8 of the Purchase Agreement and
               such other matter as such Holder may reasonably request, and in
               any event including a statement to the

                                       11

<PAGE>

               effect that such counsel has participated in conferences with
               officers and other representatives of the Company and the
               Guarantors, representatives of the independent public accountants
               for the Company and the Guarantors and have considered the
               matters required to be stated therein and the statements
               contained therein, although such counsel has not independently
               verified the accuracy, completeness or fairness of such
               statements; and that such counsel advises that, on the basis of
               the foregoing (relying as to materiality to the extent such
               counsel deems appropriate upon the statements of officers and
               other representatives of the Company and the Guarantors), no
               facts came to such counsel's attention that caused such counsel
               to believe that the applicable Registration Statement, at the
               time such Registration Statement or any post-effective amendment
               thereto became effective and, in the case of the Exchange Offer
               Registration Statement, as of the date of Consummation of the
               Exchange Offer, contained an untrue statement of a material fact
               or omitted to state a material fact required to be stated therein
               or necessary to make the statements therein not misleading, or
               that the Prospectus contained in such Registration Statement as
               of its date and, in the case of the opinion dated the date of
               Consummation of the Exchange Offer, as of the date of
               Consummation, contained an untrue statement of a material fact or
               omitted to state a material fact necessary in order to make the
               statements therein, in the light of the circumstances under which
               they were made, not misleading. Without limiting the foregoing,
               such counsel may state further that such counsel assumes no
               responsibility for, and has not independently verified, the
               accuracy, completeness or fairness of the financial statements,
               notes and schedules and other financial data included in any
               Registration Statement contemplated by this Agreement or the
               related Prospectus; and

                    (3) customary comfort letters, dated the date of
               Consummation of the Exchange Offer, or as of the date of
               effectiveness of the Shelf Registration Statement, as the case
               may be, from the Company's independent accountants, in the
               customary form and covering matters of the type customarily
               covered in comfort letters to underwriters in connection with
               underwritten offerings, and affirming the matters set forth in
               the comfort letters delivered pursuant to Section 8(g) of the
               Purchase Agreement; and

               (B) deliver such other documents and certificates as may be
          reasonably requested by the selling Holders to evidence compliance
          with the matters covered in clause (A) above and with any customary
          conditions contained in the any agreement entered into by the Company
          and the Guarantors pursuant to this clause (xi);

          (xii) prior to any public offering of Transfer Restricted Securities,
     cooperate with the selling Holders and their counsel in connection with the
     registration and qualification of the Transfer Restricted Securities under
     the securities or Blue Sky laws of

                                       12

<PAGE>

     such jurisdictions as the selling Holders may request and do any and all
     other acts or things necessary or advisable to enable the disposition in
     such jurisdictions of the Transfer Restricted Securities covered by the
     applicable Registration Statement; provided, however, that neither the
     Company nor any Guarantor shall be required to register or qualify as a
     foreign corporation where it is not now so qualified or to take any action
     that would subject it to the service of process in suits or to taxation,
     other than as to matters and transactions relating to the Registration
     Statement, in any jurisdiction where it is not now so subject;

          (xiii) in connection with any sale of Transfer Restricted Securities
     that will result in such securities no longer being Transfer Restricted
     Securities, cooperate with the Holders to facilitate the timely preparation
     and delivery of certificates representing Transfer Restricted Securities to
     be sold and not bearing any restrictive legends; and to register such
     Transfer Restricted Securities in such denominations and such names as the
     selling Holders may request at least two Business Days prior to such sale
     of Transfer Restricted Securities;

          (xiv) use their respective best efforts to cause the disposition of
     the Transfer Restricted Securities covered by the Registration Statement to
     be registered with or approved by such other governmental agencies or
     authorities as may be necessary to enable the seller or sellers thereof to
     consummate the disposition of such Transfer Restricted Securities, subject
     to the proviso contained in clause (xii) above;

          (xv) provide a CUSIP number for all Transfer Restricted Securities not
     later than the effective date of a Registration Statement covering such
     Transfer Restricted Securities and provide the Trustee under the Indenture
     with printed certificates for the Transfer Restricted Securities which are
     in a form eligible for deposit with the Depository Trust Company;

          (xvi) otherwise use their respective best efforts to comply with all
     applicable rules and regulations of the Commission, and make generally
     available to its security holders with regard to any applicable
     Registration Statement, as soon as practicable, a consolidated earnings
     statement meeting the requirements of Rule 158 (which need not be audited)
     covering a twelve-month period beginning after the effective date of the
     Registration Statement (as such term is defined in paragraph (c) of Rule
     158 under the Act);

          (xvii) cause the Indenture to be qualified under the TIA not later
     than the effective date of the first Registration Statement required by
     this Agreement and, in connection therewith, cooperate with the Trustee and
     the Holders to effect such changes to the Indenture as may be required for
     such Indenture to be so qualified in accordance with the terms of the TIA;
     and execute and use its best efforts to cause the Trustee to execute, all
     documents that may be required to effect such changes and all other forms
     and documents required to be filed with the Commission to enable such
     Indenture to be so qualified in a timely manner; and

                                       13

<PAGE>

          (xviii) provide promptly to each Holder, upon request, each document
     filed with the Commission pursuant to the requirements of Section 13 or
     Section 15(d) of the Exchange Act.

     (d) Restrictions on Holders. Each Holder agrees by acquisition of a
Transfer Restricted Security that, upon receipt of the notice referred to in
Section 6(c)(iii)(C) hereof or any notice from the Company of the existence of
any fact of the kind described in Section 6(c)(iii)(D) hereof (in each case, a
"Suspension Notice"), such Holder will forthwith discontinue disposition of
Transfer Restricted Securities pursuant to the applicable Registration Statement
until (i) such Holder has received copies of the supplemented or amended
Prospectus contemplated by Section 6(c)(iv) hereof, or (ii) such Holder is
advised in writing by the Company that the use of the Prospectus may be resumed,
and has received copies of any additional or supplemental filings that are
incorporated by reference in the Prospectus (in each case, the "Recommencement
Date"). Each Holder receiving a Suspension Notice hereby agrees that it will
either (i) destroy any Prospectuses, other than permanent file copies, then in
such Holder's possession which have been replaced by the Company with more
recently dated Prospectuses or (ii) deliver to the Company (at the Company's
expense) all copies, other than permanent file copies, then in such Holder's
possession of the Prospectus covering such Transfer Restricted Securities that
was current at the time of receipt of the Suspension Notice. The time period
regarding the effectiveness of such Registration Statement set forth in Section
3 or Section 4 hereof, as applicable, shall be extended by a number of days
equal to the number of days in the period from and including the date of
delivery of the Suspension Notice to the date of delivery of the Recommencement
Date.

SECTION 7. REGISTRATION EXPENSES

     (a) All expenses incident to the Company's and the Guarantors' performance
of or compliance with this Agreement will be borne by the Company, regardless of
whether a Registration Statement becomes effective, including without
limitation: (i) all registration and filing fees and expenses; (ii) all fees and
expenses of compliance with federal securities and state Blue Sky or securities
laws; (iii) all expenses of printing (including printing certificates for the
Series B Notes to be issued in the Exchange Offer and printing of Prospectuses),
messenger and delivery services and telephone; (iv) all fees and disbursements
of counsel for the Company and the Guarantors; (v) all application and filing
fees in connection with listing the Series B Notes on a national securities
exchange or automated quotation system pursuant to the requirements hereof; and
(vi) all fees and disbursements of independent certified public accountants of
the Company and the Guarantors (including the expenses of any special audit and
comfort letters required by or incident to such performance).

     The Company will, in any event, bear its and the Guarantors' internal
expenses (including, without limitation, all salaries and expenses of its
officers and employees performing legal or accounting duties), the expenses of
any annual audit and the fees and expenses of any Person, including special
experts, retained by the Company or the Guarantors.

     (b) In connection with any Shelf Registration Statement required by this
Agreement, the Company and the Guarantors will reimburse the Initial Purchasers
and the Holders of Transfer Restricted Securities who are tendering Series A
Notes into in the Exchange Offer

                                       14

<PAGE>

and/or selling or reselling Series A Notes or Series B Notes pursuant to the
"Plan of Distribution" contained in the Exchange Offer Registration Statement or
the Shelf Registration Statement, as applicable, for the reasonable fees and
disbursements of not more than one counsel, who shall be Latham & Watkins,
unless another firm shall be chosen by the Holders of a majority in principal
amount of the Transfer Restricted Securities for whose benefit such Registration
Statement is being prepared.

SECTION 8. INDEMNIFICATION

     (a) The Company and the Guarantors agree, jointly and severally, to
indemnify and hold harmless each Holder, its directors, officers and each
Person, if any, who controls such Holder (within the meaning of Section 15 of
the Act or Section 20 of the Exchange Act), from and against any and all losses,
claims, damages, liabilities, judgments, (including without limitation, any
legal or other expenses incurred in connection with investigating or defending
any matter, including any action that could give rise to any such losses,
claims, damages, liabilities or judgments) caused by any untrue statement or
alleged untrue statement of a material fact contained in any Registration
Statement, preliminary prospectus or Prospectus (or any amendment or supplement
thereto) provided by the Company to any Holder or any prospective purchaser of
Series B Notes or registered Series A Notes, or caused by any omission or
alleged omission to state therein a material fact required to be stated therein
or necessary to make the statements therein not misleading, except insofar as
such losses, claims, damages, liabilities or judgments are caused by an untrue
statement or omission or alleged untrue statement or omission that is based upon
information relating to any Holder furnished in writing to the Company by any
such Holder.

     (b) Each Holder of Transfer Restricted agrees, severally and not jointly,
to indemnify and hold harmless the Company and the Guarantors, and their
respective directors and officers, and each person, if any, who controls (within
the meaning of Section 15 of the Act or Section 20 of the Exchange Act) the
Company, or the Guarantors to the same extent as the foregoing indemnity from
the Company and the Guarantors set forth in section (a) above, but only with
reference to information relating to such Holder furnished in writing to the
Company by such Holder expressly for use in any Registration Statement. In no
event shall any Holder, its directors, officers or any Person who controls such
Holder be liable or responsible for any amount in excess of the amount by which
the total amount received by such Holder with respect to its sale of Transfer
Restricted Securities pursuant to a Registration Statement exceeds (i) the
amount paid by such Holder for such Transfer Restricted Securities and (ii) the
amount of any damages that such Holder, its directors, officers or any Person
who controls such Holder has otherwise been required to pay by reason of such
untrue or alleged untrue statement or omission or alleged omission.

     (c) In case any action shall be commenced involving any person in respect
of which indemnity may be sought pursuant to Section 8(a) or Section 8(b) hereof
(the "indemnified party"), the indemnified party shall promptly notify the
person against whom such indemnity may be sought (the "indemnifying person") in
writing and the indemnifying party shall assume the defense of such action,
including the employment of counsel reasonably satisfactory to the indemnified
party and the payment of all fees and expenses of such counsel, as incurred
(except that in the case of any action in respect of which indemnity may be
sought pursuant to both

                                       15

<PAGE>

Sections 8(a) and 8(b) hereof, a Holder shall not be required to assume the
defense of such action pursuant to this Section 8(c), but may employ separate
counsel and participate in the defense thereof, but the fees and expenses of
such counsel, except as provided below, shall be at the expense of the Holder).
Any indemnified party shall have the right to employ separate counsel in any
such action and participate in the defense thereof, but the fees and expenses of
such counsel shall be at the expense of the indemnified party unless (i) the
employment of such counsel shall have been specifically authorized in writing by
the indemnifying party, (ii) the indemnifying party shall have failed to assume
the defense of such action or employ counsel reasonably satisfactory to the
indemnified party or (iii) the named parties to any such action (including any
impleaded parties) include both the indemnified party and the indemnifying
party, and the indemnified party shall have been advised by such counsel that
there may be one or more legal defenses available to it which are different from
or additional to those available to the indemnifying party (in which case the
indemnifying party shall not have the right to assume the defense of such action
on behalf of the indemnified party). In any such case, the indemnifying party
shall not, in connection with any one action or separate but substantially
similar or related actions in the same jurisdiction arising out of the same
general allegations or circumstances, be liable for the fees and expenses of
more than one separate firm of attorneys (in addition to any local counsel) for
all indemnified parties and all such fees and expenses shall be reimbursed as
they are incurred. Such firm shall be designated in writing by a majority of the
Holders, in the case of the parties indemnified pursuant to Section 8(a) hereof,
and by the Company and Guarantors, in the case of parties indemnified pursuant
to Section 8(b) hereof. The indemnifying party shall indemnify and hold harmless
the indemnified party from and against any and all losses, claims, damages,
liabilities and judgments by reason of any settlement of any action (i) effected
with its written consent or (ii) effected without its written consent if the
settlement is entered into more than twenty business days after the indemnifying
party shall have received a request from the indemnified party for reimbursement
for the fees and expenses of counsel (in any case where such fees and expenses
are at the expense of the indemnifying party) and, prior to the date of such
settlement, the indemnifying party shall have failed to comply with such
reimbursement request. No indemnifying party shall, without the prior written
consent of the indemnified party, effect any settlement or compromise of, or
consent to the entry of judgment with respect to, any pending or threatened
action in respect of which the indemnified party is or could have been a party
and indemnity or contribution may be or could have been sought hereunder by the
indemnified party, unless such settlement, compromise or judgment (i) includes
an unconditional release of the indemnified party from all liability on claims
that are or could have been the subject matter of such action and (ii) does not
include a statement as to or an admission of fault, culpability or a failure to
act, by or on behalf of the indemnified party.

     (d) To the extent that the indemnification provided for in this Section 8
is unavailable to an indemnified party in respect of any losses, claims,
damages, liabilities or judgments referred to therein, then each indemnifying
party, in lieu of indemnifying such indemnified party, shall contribute to the
amount paid or payable by such indemnified party as a result of such losses,
claims, damages, liabilities or judgments (i) in such proportion as is
appropriate to reflect the relative benefits received by the Company and the
Guarantors, on the one hand, and the Holders, on the other hand, from their sale
of Transfer Restricted Securities or (ii) if the allocation provided by clause
8(d)(i) hereof is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause
8(d)(i) above but also the relative fault of the Company and the Guarantors, on
the one hand, and of the

                                       16

<PAGE>

Holder, on the other hand, in connection with the statements or omissions which
resulted in such losses, claims, damages, liabilities or judgments, as well as
any other relevant equitable considerations. The relative fault of the Company
and the Guarantors, on the one hand, and of the Holder, on the other hand, shall
be determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information supplied by the Company or such
Guarantor, on the one hand, or by the Holder, on the other hand, and the
parties' relative intent, knowledge, access to information and opportunity to
correct or prevent such statement or omission. The amount paid or payable by a
party as a result of the losses, claims, damages, liabilities and judgments
referred to above shall be deemed to include, subject to the limitations set
forth in the second paragraph of Section 8(a) hereof, any legal or other fees or
expenses reasonably incurred by such party in connection with investigating or
defending any action or claim.

     The Company, the Guarantors and each Holder agree that it would not be just
and equitable if contribution pursuant to this Section 8(d) were determined by
pro rata allocation (even if the Holders were treated as one entity for such
purpose) or by any other method of allocation which does not take account of the
equitable considerations referred to in the immediately preceding paragraph. The
amount paid or payable by an indemnified party as a result of the losses,
claims, damages, liabilities or judgments referred to in the immediately
preceding paragraph shall be deemed to include, subject to the limitations set
forth above, any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending any matter, including any
action that could have given rise to such losses, claims, damages, liabilities
or judgments. Notwithstanding the provisions of this Section 8, no Holder, its
directors, its officers or any Person, if any, who controls such Holder shall be
required to contribute, in the aggregate, any amount in excess of the amount by
which the total received by such Holder with respect to the sale of Transfer
Restricted Securities pursuant to a Registration Statement exceeds (i) the
amount paid by such Holder for such Transfer Restricted Securities and (ii) the
amount of any damages which such Holder has otherwise been required to pay by
reason of such untrue or alleged untrue statement or omission or alleged
omission. No person guilty of fraudulent misrepresentation (within the meaning
of Section 11(f) of the Act) shall be entitled to contribution from any person
who was not guilty of such fraudulent misrepresentation. The Holders'
obligations to contribute pursuant to this Section 8(d) are several in
proportion to the respective principal amount of Transfer Restricted Securities
held by each Holder hereunder and not joint.

SECTION 9. RULE 144A AND RULE 144

     The Company and each Guarantor agrees with each Holder, for so long as any
Transfer Restricted Securities remain outstanding and during any period in which
the Company or such Guarantor (i) is not subject to Section 13 or 15(d) of the
Exchange Act, to make available, upon request of any Holder, to such Holder or
beneficial owner of Transfer Restricted Securities in connection with any sale
thereof and any prospective purchaser of such Transfer Restricted Securities
designated by such Holder or beneficial owner, the information required by Rule
144A(d)(4) under the Act in order to permit resales of such Transfer Restricted
Securities pursuant to Rule 144A, and (ii) is subject to Section 13 or 15 (d) of
the Exchange Act, to make all filings required thereby in a timely manner in
order to permit resales of such Transfer Restricted Securities pursuant to Rule
144.

                                       17

<PAGE>

SECTION 10. MISCELLANEOUS

     (a) Remedies. The Company and the Guarantors acknowledge and agree that any
failure by the Company and/or the Guarantors to comply with their respective
obligations under Section 3 and Section 4 hereof may result in material
irreparable injury to the Initial Purchasers or the Holders for which there is
no adequate remedy at law, that it will not be possible to measure damages for
such injuries precisely and that, in the event of any such failure, the Initial
Purchasers or any Holder may obtain such relief as may be required to
specifically enforce the Company's and the Guarantor's obligations under Section
3 and Section 4 hereof. The Company and the Guarantors further agree to waive
the defense in any action for specific performance that a remedy at law would be
adequate.

     (b) No Inconsistent Agreements. Neither the Company nor any Guarantor will,
on or after the date of this Agreement, enter into any agreement with respect to
its securities that is inconsistent with the rights granted to the Holders in
this Agreement or otherwise conflicts with the provisions hereof. Neither the
Company nor any Guarantor has previously entered into any agreement granting any
registration rights with respect to its securities to any Person. The rights
granted to the Holders hereunder do not in any way conflict with and are not
inconsistent with the rights granted to the holders of the Company's and the
Guarantors' securities under any agreement in effect on the date hereof.

     (c) Amendments and Waivers. The provisions of this Agreement may not be
amended, modified or supplemented, and waivers or consents to or departures from
the provisions hereof may not be given unless (i) in the case of Section 5
hereof and this Section 10(c)(i), the Company has obtained the written consent
of Holders of all outstanding Transfer Restricted Securities and (ii) in the
case of all other provisions hereof, the Company has obtained the written
consent of Holders of a majority of the outstanding principal amount of Transfer
Restricted Securities (excluding Transfer Restricted Securities held by the
Company or its Affiliates). Notwithstanding the foregoing, a waiver or consent
to departure from the provisions hereof that relates exclusively to the rights
of Holders whose Transfer Restricted Securities are being tendered pursuant to
the Exchange Offer, and that does not affect directly or indirectly the rights
of other Holders whose Transfer Restricted Securities are not being tendered
pursuant to such Exchange Offer, may be given by the Holders of a majority of
the outstanding principal amount of Transfer Restricted Securities subject to
such Exchange Offer.

     (d) Third Party Beneficiary. The Holders shall be third party beneficiaries
to the agreements made hereunder between the Company and the Guarantors, on the
one hand, and the Initial Purchasers, on the other hand, and shall have the
right to enforce such agreements directly to the extent they may deem such
enforcement necessary or advisable to protect its rights or the rights of
Holders hereunder.

     (e) Notices. All notices and other communications provided for or permitted
hereunder shall be made in writing by hand-delivery, first-class mail
(registered or certified, return receipt requested), telex, telecopier, or air
courier guaranteeing overnight delivery:

          (i) if to a Holder, at the address set forth on the records of the
     Registrar under the Indenture, with a copy to the Registrar under the
     Indenture; and

                                       18

<PAGE>

          (ii) if to the Company or the Guarantors:

                    Roundy's, Inc.
                    23000 Roundy Drive
                    Pewaukee, Wisconsin 53072
                    Telecopier No.: (262) 953-7989
                    Attention: Chief Financial Officer

                    With a copy to:

                    Kirkland & Ellis
                    200 East Rudolph Drive
                    Chicago, Illinois 60601
                    Telecopier No.: (312) 861-2200
                    Attention: Dennis Myers and
                               Gerald Nowak

     All such notices and communications shall be deemed to have been duly
given: at the time delivered by hand, if personally delivered; five Business
Days after being deposited in the mail, postage prepaid, if mailed; when receipt
acknowledged, if telecopied; and on the next business day, if timely delivered
to an air courier guaranteeing overnight delivery.

     Copies of all such notices, demands or other communications shall be
concurrently delivered by the Person giving the same to the Trustee at the
address specified in the Indenture.

     (f) Successors and Assigns. This Agreement shall inure to the benefit of
and be binding upon the successors and assigns of each of the parties, including
without limitation and without the need for an express assignment, subsequent
Holders; provided, that nothing herein shall be deemed to permit any assignment,
transfer or other disposition of Transfer Restricted Securities in violation of
the terms hereof or of the Purchase Agreement or the Indenture. If any
transferee of any Holder shall acquire Transfer Restricted Securities in any
manner, whether by operation of law or otherwise, such Transfer Restricted
Securities shall be held subject to all of the terms of this Agreement, and by
taking and holding such Transfer Restricted Securities such Person shall be
conclusively deemed to have agreed to be bound by and to perform all of the
terms and provisions of this Agreement, including the restrictions on resale set
forth in this Agreement and, if applicable, the Purchase Agreement, and such
Person shall be entitled to receive the benefits hereof.

     (g) Counterparts. This Agreement may be executed in any number of
counterparts and by the parties hereto in separate counterparts, each of which
when so executed shall be deemed to be an original and all of which taken
together shall constitute one and the same agreement.

     (h) Headings. The headings in this Agreement are for convenience of
reference only and shall not limit or otherwise affect the meaning hereof.

                                       19

<PAGE>

     (i) Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN
ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO THE
CONFLICT OF LAW RULES THEREOF.

     (j) Severability. In the event that any one or more of the provisions
contained herein, or the application thereof in any circumstance, is held
invalid, illegal or unenforceable, the validity, legality and enforceability of
any such provision in every other respect and of the remaining provisions
contained herein shall not be affected or impaired thereby.

     (k) Entire Agreement. This Agreement is intended by the parties as a final
expression of their agreement and intended to be a complete and exclusive
statement of the agreement and understanding of the parties hereto in respect of
the subject matter contained herein. There are no restrictions, promises,
warranties or undertakings, other than those set forth or referred to herein
with respect to the registration rights granted with respect to the Transfer
Restricted Securities. This Agreement supersedes all prior agreements and
understandings between the parties with respect to such subject matter.

                                       20

<PAGE>

     IN WITNESS WHEREOF, the parties have executed this Agreement as of the date
first written above.

                                   ROUNDY'S, INC.

                                   By:  /s/ Darren W. Karst
                                      ------------------------------------------
                                      Name: Darren Karst
                                      Title: Chief Financial Officer

                                   GUARANTORS:
                                      Cardinal Foods, Inc.
                                      Holt Public Storage, Inc.
                                      Insurance Planners, Inc.
                                      I.T.A., Inc.
                                      Jondex Corp.
                                      Kee Trans, Inc.
                                      Mega Marts, Inc.
                                      Midland Grocery of Michigan, Inc.
                                      Pick 'n Save Warehouse Foods, Inc.
                                      Ropak, Inc.
                                      Rindt Enterprises, Inc.
                                      Scot Lad Foods, Inc.
                                      Scot Lad-Lima, Inc.
                                      Shop-Rite, Inc.
                                      Spring Lake Merchandise, Inc.
                                      The Copps Corporation
                                      The Midland Grocery Company
                                      Ultra Mart Foods, Inc.

                                   By:  /s/ Edward G. Kitz
                                      ------------------------------------------
                                      Name: Edward G. Kitz
                                      Title: Secretary

                                      Village Market, LLC

                                   By:  /s/ Edward G. Kitz
                                      ------------------------------------------
                                      Name: Edward G. Kitz, signing on behalf of
                                            Shop-Rite, Inc., in its capacity as
                                            managing member of Village Market,
                                            LLC
                                      Title: Secretary of Shop-Rite, Inc.

                          Registration Rights Agreement

<PAGE>

BEAR STEARNS & CO. INC.

By: /s/ ILLEGIBLE
   --------------------------------
   Name:
   Title:

CIBC WORLD MARKETS CORP.

By: /s/ Brian Perman
   --------------------------------
   Name:   Brian Perman
   Title:  Managing Director

                          Registration Rights Agreement

<PAGE>

                                   SCHEDULE A

                                   GUARANTORS

Cardinal Foods, Inc.
Holt Public Storage, Inc.
Insurance Planners, Inc.
I.T.A., Inc.
Jondex Corp.
Kee Trans, Inc.
Mega Marts, Inc.
Midland Grocery of Michigan, Inc.
Pick 'n Save Warehouse Foods, Inc.
Ropak, Inc.
Rindt Enterprises, Inc.
Scot Lad Foods, Inc.
Scot Lad-Lima, Inc.
Shop-Rite, Inc.
Spring Lake Merchandise, Inc.
The Copps Corporation
The Midland Grocery Company
Ultra Mart Foods, Inc.
Village Market, LLC

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}]]